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A novel freeze-quench instrument with a characteristic «dead-time» of 137F 18 As is reported. The prototype has several key features that
distinguish it from conventional freeze-quench devices and provide a significant improvement in time resolution: (a) high operating pressures
(up to 400 bar) result in a sample flow with high linear rates (up to 200 m s 1); (b) tangential micro-mixer with an operating volume of f 1
nl yields short mixing times (up to 20 As); (c) fast transport between the mixer and the cryomedium results in short reaction times: the ageing
solution exits the mixer as a free-flowing jet, and the chemical reaction occurs ‘‘in–flight’’ on the way to the cryomedium; (d) a small jet
diameter (f 20 Am) and a high jet velocity (f 200 m s 1) provide high sample-cooling rates, resulting in a short cryofixation time (up to
30 As). The dynamic range of the freeze-quench device is between 130 As and 15 ms. The novel tangential micro-mixer efficiently mixes
viscous aqueous solutions, showing more than 95% mixing at gV 4 (equivalent to protein concentrations up to 250 mg ml 1), which makes
it an excellent tool for the preparation of pre-steady state samples of concentrated protein solutions for spectroscopic structure analysis. The
novel freeze-quench device is characterized using the reaction of binding of azide to metmyoglobin from horse heart. Reaction samples are
analyzed using 77 K optical absorbance spectroscopy, and X–band EPR spectroscopy. A simple procedure of spectral analysis is reported
that allows (a) to perform a quantitative analysis of the reaction kinetics and (b) to identify and characterize novel reaction intermediates. The
reduction of dioxygen by the bo3-type quinol oxidase from Escherichia coli is assayed using the MHQ technique. In these pilot experiments,
low-temperature optical absorbance measurements show the rapid oxidation of heme o3 in the first 137 As of the reaction, accompanied by
the formation of an oxo-ferryl species. X-band EPR spectroscopy shows that a short-living radical intermediate is formed during the
oxidation of heme o3. The radical decays within f 1 ms concomitant with the oxidation of heme b, and can be attributed to the PM reaction
intermediate converting to the oxoferryl intermediate F. The general field of application of the freeze-quench methodology is discussed.
D 2004 Elsevier B.V. All rights reserved.Keywords: Pre-steady state kinetics; Freeze-quench; Hyperquenching; Transient intermediate; Cytochrome bo3 oxidase; Radical; Myoglobin
1. Introduction unsolved: the direct experimental correlation between theKinetic analysis of enzyme-promoted chemical reactions
is an important approach in biological chemistry, which is
used to define, characterize, and elucidate the chemical
mechanics of biocatalysis. Since the seminal work in this
field by Fischer in 1894 [1], and Michaelis and Menten in
1913 [2], countless numbers of proteins have been studied
and their catalytic properties described and characterized
well [3,4]. However, despite the wide and acclaimed use of
this approach, the fundamental problem remains in general0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2004.02.006
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E-mail address: S.deVries@tnw.tudelft.nl (S. de Vries).kinetics of the chemical reaction and the spatially well-
defined dynamics of the enzyme structure cannot be estab-
lished. The reason stems from the lack of experimental
techniques for both preparation of the transient kinetic
samples and analysis of their structures.
In this paper, we review and report the latest advances in
mixing-and-sampling technology that bring freeze-quench-
ing forth as a potential method of choice to prepare transient
kinetic samples for structural analysis.
In general, freeze-quenching is a three-stage process,
which gives a unique opportunity (a) to initiate/synchronize
a chemical reaction by rapidly mixing the reaction compo-
nents, (b) to vary the reaction time by delivering a sample to
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capture transient intermediates by suddenly freezing the
reaction mixture. Freeze-quenched samples can be stored
at low temperatures for a long period of time, and their
structure can be analyzed using different spectroscopic
techniques.
The success of the method depends on two key
parameters. It is essential (a) to vary the reaction time
in a wide range (As–ms–s), so that the entire turnover of
an enzyme can be assessed, and (b) to minimize the
temporal ‘‘dilution’’ of transient kinetic intermediates. To
achieve the latter, the mixing of the reaction components,
the diffusion-dependent binding, and the cryofixation of
the reacting sample have to be set considerably faster
than the first-order catalysis. Ideally, all second-order
events should be over within the time of mixing, while
the first-order events should not have yet started. Under
these circumstances, there is a chance to observe a ‘‘slide
show’’ of reaction intermediates as the sample moves
towards the cryomedium, where the intermediates are
captured by rapid freezing.
In general, proteins in solution experience a wide
spectrum of dynamic fluctuations that span the time scales
from femtoseconds to milliseconds, involving residues that
are located at the protein–solvent interface or are im-
mersed in the protein matrix [5–7]. Molecular tumbling
of the protein molecule [8,9], ‘‘breathing’’ [10], motions of
the side chains of individual residues [6,7,11], movements
of secondary, tertiary, and quaternary structure elements
[12,13] can all be distinguished [14–16]. In addition, the
proteins may undergo rapid disorder-to-order transitions,
e.g. ordered state–molten globule–random coil upon bind-
ing and catalysis [17]. On the other hand, chemical
catalysis in this multifactorial system rarely occurs with
turnover numbers higher than 106 s 1 [18–20], with the
exception of some rapid light-driven biological processes
[21–28]. Thus, the specific conformational changes that
the enzymes are using to steer the chemical events during
catalysis, and that are of primary interest for the structural
analysis, are mainly confined to the micro- and millisecond
time domain. There are many examples, when the motions
of the primary and/or secondary structure elements with
characteristic times of 10 2–10 6 s were observed and
assigned to a particular step of chemical catalysis [29–40].
Triosephosphate isomerase is a representative example,
where a motion of a single 10-residue-long loop in the
active site of the enzyme controls the entire catalytic cycle,
facilitating, in an open form, binding and release of a
ligand, and, in a closed form, controlling the formation and
protecting the reaction intermediates [41–43]. Another
example involves cyclophilins, where the dynamics of a
single arginine residue plays a critical role in the catalysis
of the cis/trans isomerization of peptidyl/prolyl bond
during catalysis [44,45]. Dihydrofolate reductase is the
enzyme that catalyzes the NADPH-dependent reduction
of 5,6,7,8-tetrahydrofolate, the essential component forthe biosynthesis of purines and certain amino acids. In
this enzyme, the mobility of two loops (Met20 and bF-bG)
was shown to control the formation of the enzyme–
substrate Michaelis complex, as well as to regulate the
release of the product [6,46–48].
In relation to the freeze-quenching method, these and
other examples of structural enzyme kinetics pose clear
time limitations on the three main steps of the sample
preparation process. To avoid ‘‘dilution’’ of conformational
intermediates, mixing and cryofixation of the sample
should occur within 1–10 As, while the sample-transport
‘‘dead’’ time should not exceed 10–100 As. An overview
of the current state of the freeze-quenching technology
leads to the conclusion that none of the individual steps of
the sample preparation process comply with these essential
requirements. Taking as example the ‘‘Ballou’’ freeze-
quench instrument reported in Refs. [49,50], the minimal
sample mixing time can be estimated as f 1 ms, the
transport time 1–2 ms, and the time of cryofixation, owing
to the low linear velocity of the sample flow and large jet
diameter, as long as 2 ms [51,52]. As a result, the
characteristic ‘‘dead’’ time of sample preparation for this
and similar commercially available devices is around 5 ms
[53–57].
Despite its low time resolution, the conventional ‘‘rap-
id’’ freeze-quench technique (RFQ) is widely used, and a
wealth of mechanistic studies have been performed on the
catalysis and reactivity of metal centers in biological
systems [58–69], in particular the studies on bioreduction
of molecular oxygen [53,70–75]. As a well-characterized
example, carboxylate-bridged diiron(II) cluster can be
brought forth, the reaction center that defines the modus
operandi of a wide class of proteins, ribonucleotide
reductases (RNR), such as class I RNR from E. coli
[76,77], bacterial hydrocarbon hydroxylases, such as solu-
ble methane monooxygenase (MMO) from methanotrophs
Methylococcus capsulatus and Methylosinus trichosporium
[78–80], ferritins [81–83], and plant fatty acyl desa-
turases, such as stearoyl acyl carrier protein D9-desaturase
from castor seeds [84,85]. The diiron reaction center
catalyzes the reductive oxidation of molecular oxygen,
which is slow compared with the similar reaction of a
binuclear iron-copper center of cytochrome c oxidase [86–
95], and thus it is accessible for mechanistic studies using
the RFQ technique. The mechanism of dioxygen reduction
by the diiron (II) cluster is quite complex; it includes
several reaction intermediates, and involves both short- and
long-living radical species. Taking the example of RNR,
activation of the molecular oxygen leads to the formation
of the dinuclear ferric cluster-tyrosyl radical cofactor [96–
98]; the latter generates the catalytic thiyl radical via long-
range coupled electron and proton transfer [99–101],
essential for the reduction of the ribonucleotide [102–
104]. The four-electron O2 reduction proceeds via the
formation of a transient tryptophan cation radical (W+ )
and the mixed valence Fe(III)/Fe(IV) species (X) [88,105–
Table 1
Technical specifications of the MHQ instrument vs. previous apparatus
[49,50]
This work [49,50]
Pre-mixing volume, nl 1F0.1 960
(Am) (12012060) (15881588381)
Mixing volume, pl 10F1 6.8104 (68 nl)
Orifice diameter, Am 20F1 330
pre-mixing chamber <1000 <5000
Re*
Orifice <4000 <7000
Backpressure, bar (psi) 0–417 (0–6000) f0–5 (0–70)
Flow rate, ml min1 0.4–3.6 36–109
Jet speed, m s1 20–200 1–10z
Spraying distance, cmy 2–30 >2
Dynamic range, ms 0.1–14 >5
y With liquid cryomedium.
z Linear flow rate in the sample delivery tubing.
* Reynolds number.
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diate similar to compound P of MMO [90,108,109]
precedes the XW+  diradical species along the reaction
coordinate [86,110–113], though, not without a controver-
sy [88]. The existence of a ‘‘kinetically masked’’ non-
covalent O2-bound diiron(II)-intermediate [88] (similar to
the compound A of cytochrome c oxidase [114]) has been
suggested [106].
For a detailed understanding of the reaction mechanism
of the protein–metal redox reaction center, it is pertinent
to follow the time-resolved changes of (i) metal oxidation
states, (ii) metal–ligand and metal–metal bond lengths,
(iii) ligand– ligand and metal– ligand bond stretching
frequencies, and (iv) the nature of the catalytic radicals.
For this purpose, in the case of the carboxylate-bridged
diiron(II) cluster RFQ sampling has been coupled to
sample analyses by UV–Vis absorbance, EPR, ENDOR,
EXAFS, resonance Raman, and Mo¨ssbauer spectroscopy.
Combined data from UV–Vis, RFQ-EPR and RFQ-Mo¨ss-
bauer analyses allowed detection and characterization of
the tryptophan cation radical, as well as to show that it is
formed simultaneously with the mixed valence intermedi-
ate X [88,105,115], donating the fourth electron for the
reduction of oxygen [106]. Use of RFQ-EPR allowed
detection and characterization of the mixed valence inter-
mediate X [105,116–118], tyrosyl- [105,117,118], and
thiyl- [104,119,120] radicals. Mo¨ssbauer studies [105,
115,118,121], coupled with resonance Raman and EXAFS
analyses [122,123], supported by the ENDOR results
[116,124–126], allowed structural identification of X,
and A-(oxo)diiron(III) species in the diferric tyrosyl rad-
ical cofactor [88]. Unfortunately, the low time resolution
of RFQ technique has left several questions unanswered.
Perhaps, a submicrosecond time resolution, such as
reported in this paper for the MHQ technique, is required
to capture and characterize a non-covalent O2-bound
diiron(II)-intermediate, which was implied for MMO on
the basis of kinetic studies [88] but has not been observed
so far in the case of RNR. The same holds for the
isolation and identification of the structure of the peroxy-
intermediate for the wt RNR, which has been postulated/
reported in Refs. [86,110,112,113] and disputed in Refs.
[88,127].
In 2002 we have reported the development of a novel
method of microsecond freeze-hyperquenching (MHQ)—a
breakthrough in technology that led to a 50-fold increase
in time resolution over conventional rapid freeze-quench-
ing [128]. In the present work we describe in detail the
further advancements in the MHQ technology and instru-
mentation, and provide a general introduction to the
freeze-quench mixing-and-sampling, discussing (i) a strat-
egy for improving the overall time resolution of the
freeze-quench process, (ii) a new design of the mixer
and the freeze-quench instrument, (iii) characterization of
the novel freeze-quenching device using the reaction of
binding of azide to metmyoglobin from horse heart, and(iv) application of the method to study the mechanism of
dioxygen reduction catalyzed by the bo3-type quinol
oxidase from E. coli.2. Review, results and discussions
2.1. Freeze-quench technology—problems and solution
strategy
In general, the freeze-quench mixing-and-sampling tech-
nique can be viewed as a three-stage process. At the first
stage, the chemical reaction is initiated by rapid mixing of
the reaction components. The reaction chemistry occurs
during the second stage, when the sample is transported
from the mixer to the cryomedium surface. At the third
stage, the reacting sample is suddenly frozen in the cry-
omedium, and the chemical reaction is captured in some
intermediate state [129–132].
The characteristic sample-ageing time, sa, can thus be
resolved into three terms,
sa ¼ sm þ st þ sc ð1Þ
sm is the mixing time, st is the sample-transport time, and sc
is the cryofixation time.
Below, we pinpoint and discuss the limitations of each
stage of the freeze-quench process, as well as outline the
solution strategy that was used in the present work.
2.1.1. Mixing
Two main parameters determine the time resolution of
the mixing process, (i) the sample flow rate, and (ii) the
operating volume of the mixer [133].
In the conventional freeze-quench devices [49,50,53,
55,132], the mixing time is quite long, smf 1 ms even at
Fig. 1. Dependence of the sample-ageing time on the linear flow rate of the
sample and the operating pressure of the mixing-and-sampling instrument.
The correlation between dynamic pressure and the linear flow rate (dotted
trace) was obtained by fitting Eq. (2) to the experimental data (solid circles)
(with kinetic energy coefficient a= 2, and friction coefficient Cv =
0.88F 0.03). Dynamic pressure in the mixer was measured as a function
of the volumetric flow rate. The values of the linear flow rate have been
calculated using the values of the volumetric flow rate and the orifice
diameter, plus the 10% increase of the linear flow velocity as measured by
LDA. Axes (A, D)—sample-ageing time calculated for the MHQ setup
reported in this work (mixer volume—1 nl, the diameter of the mixer orifice
and the sample jet d= 20 Am, distance between the mixer and the
cryomedium l = 2 and 20 mm, respectively). Axes (B, C)—sample-ageing
time calculated for the low-pressure stopped-flow (B) and freeze-quench
(C) instruments (stopped-flow: mixer volume—1 Al, volume of the sample
cuvette—10 Al, distance between the mixer and the cuvette l = 2 mm with a
diameter of 1 mm, total sample filling volume of 13 Al; freeze-quench: as
reported in Refs. [49,50], mixer volume—1 Al, the diameter of mixer orifice
and sample delivery tubing d= 0.3 mm, distance between the mixer and the
cryomedium surface l= 20 mm). Sample-ageing time was calculated by
adding the mixing time (the time it takes for the sample to fill the mixer
volume) and the time of sample delivery (calculated as the time it takes for
the sample with the denoted linear flow rate to travel over the distance
l between the mixer and the cryomedium. In case of the stopped-flow, the
time it takes to fill the sample observation cuvette is added. Note that the
freezing time was left out from the total sample-ageing time, enabling
comparison between the two methods (stopped-flow and freeze-quench).
Low-pressure freeze-quench and stopped-flow devices are operating at
pressures < 15 bar; high-pressure instruments may operate up to f 1 kbar;
operational rate–pressure– time areas for both low- and high-pressure
instruments are denoted with gray.
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large mixing volume (f 1 Al, Table 1).
For continuous-flow experiments, a device has been
reported that combines both a small mixing volume and
high rates of the sample flow [134]. It is based on the
design by Regenfuss et al. [135,136], where the principle
of coaxial mixing [137] is combined with the Berger-type
ball mixing [138,139], the dimensions of the mixer are
scaled down to a mixing volume of f 9 nl, and the flow
rates are kept high (f 0.6 ml/s). As a result, the mixing
time is estimated as smf 15 As [134], satisfying the
requirements for the preparation of transient reaction
samples mentioned in Introduction. However, to our opin-
ion the design of the coaxial-ball micromixer makes it
inherently impractical for the operation on a day-to-day
basis if compared to the other glass/quartz-free designs.
The coaxial micromixer contains fine internal parts of
custom design, which might be too fragile for operation
in vacuo at sample-delivery pressures of 0.1–0.4 kbar.
Thus, in this work we have pursued a different approach,
which was first introduced by Hartridge and Roughton
[133,140–142] in 1920s using the modified Rolls Royce
carburetor for mixing the reaction components. The ap-
proach is based on the principle of alternating multi-stream
mixing of the reaction components resulting in an angular
momentum (tangential mixing). The four-jet tangential
mixers are extensively used for freeze-quench experiments,
and are known for their robustness, reliability and high
mixing efficiency [49,50,57,132,143].
The challenge of this work was to design and machine
a four-jet tangential mixer with a mixing volume small
enough to reach the required sm values (f 10–20 As).
In summary, the dimensions of the mixer have been
scaled down roughly 10-fold with respect to the ‘‘Bal-
lou’’ design [49,50], resulting in a f 10-fold decrease of
the operating volume (to f 1 nl) with respect to the
coaxial-ball mixer [134], a decrease of the jet diameter to
f 20 Am, and an increase of the jet speed to f 200 m
s 1 (Table 1). The sample preparation time has increased
from ca. < 0.3 to 12–90 s, giving more possibilities to
control the quality of the sample preparation process in
situ.
2.1.2. Transport
The sample transport rate is determined by two critical
parameters, (i) the linear flow rate–pressure in the system,
and (ii) the distance between the mixer and the sampling
area.
In the conventional setup, the sample-transport time, st,
has intrinsically a large value because of the relatively low
linear flow rates ( < 20 m s 1), large mixer dimensions/
diameter of the sample-delivery tubing, long transport
distance (f 1–2 cm), and low operating pressure ( < 5
bar, 70 psi) [49,50,73,132]. Thus, to achieve 5-ms time
resolution, the volumetric flow rate has to be kept rather
high (f 1 ml/s, Table 1).The increase of the linear flow rate allows a dramatic
improvement of the time resolution, e.g. at a 200 m s 1
flow rate the transport time over l= 20 mm is as short as 100
As. Acceleration of the sample flow is associated with
pressure increase (Fig. 1), a serious technological problem,
which requires re-design of the entire freeze-quench set up.
For example, for a 200 m s 1 sample flow, the pressure
Table 2
Kinetic parameters of the reaction of the horse heart metmyoglobin with azide at 5 jC and different pH values
pH Apparent rate
constant
Low [N3
1]
( < 1 mM)
High [N3
1]
(>10 mM)
klow/khigh
y*
4 k1
app, M 1 s 1 9.3F 0.06 104 5.7F 0.2 103 16.3
k 1
app, s 1 5.7F 0.7 10 2 83F 8 1460*
Kd
app 0.61F 0.08 AM 15F 1 mM 2.4 104*
5 k1
app, M 1 s 1 2.99F 0.04 104 3.5F 0.1103 8.5
k 1
app, s 1 1.35F 0.08 10 1 57F 6 420*
Kd
app 4.5F 0.1 AM 16F 6 mM 3600*
5.5 k1
app, M 1 s 1 1.29F 0.01104 1.48F 0.05 103 8.7
k 1
app, s 1 1.37F 0.05 10 1 57F 3 420*
Kd
app 10.6F 0.6 AM 38F 3 mM 3600*
yklow—rate constant at low [N3
1], khigh—ibid. at high [N3
1]. *For k 1
app and Kd
app the ratio is inverted, khigh/klow.
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values follow the Bernoulli’s velocity/dynamic pressure
correlation (2) (Fig. 1, dotted trace).
DP ¼ a qU
2
2C2v
ð2Þ
DP is the pressure build-up in the orifice, a is the kinetic
energy coefficient (a = 2 for laminar flow, or 1.01–1.1 for
fully developed turbulent flow), q is the liquid density, U is
the linear velocity at the orifice, Cv is the wall friction
coefficient, Cv ¼ UUmax ; and Umax ¼
ﬃﬃﬃﬃﬃﬃ
2DP
aq
q
:
The high friction in the orifice (Cv = 0.88F 0.03 vs.
f 0.97–0.99 for normal flows, see legend to Fig. 1) can
possibly be attributed to the pronounced wall effects in the
micro-mixer with dimensions of 20–120 Am.
From Fig. 1 it also becomes clear that the low-pressure
‘‘stopped-flow type’’ of sample preparation that involves
pneumatically driven glass Hamilton syringes for the sample
delivery at pressures < 15 bar, is inherently limited to the
time range of >0.5 ms (over 2 mm) or >1 ms (over 2 cm).
The use of the high-pressure ‘‘HPLC-type’’ systems
becomes inevitable with entering the microsecond time
domain. In this light, two recent reports where the sample-
ageing time of 200 As has been claimed in a low-pressure
instrument [144,145], to the authors’ opinion, has to beTable 3
Kinetic and thermodynamic parameters of the reaction of the horse heart metmyo
[N3
1] < 1 mM Kd
app, M 14.9F 0.5 10 6
k1
app, M 1 s 1 9.57F 0.08 104
EA
1, kcal/mol DS1
#, cal deg 1
mol 1
9.2F 0.1  6.2F 0.5
[N3
1] >10 mM Kd
app, M 28.7F 1.2 10 3
k1
app, M 1 s 1 1.49F 0.15 104
EA
1, kcal/mol DS1
#, cal deg 1
mol 1
15.8F 1.3 12.5F 4.5
The values have been determined using the experimental data shown in Fig. 8.critically evaluated. A few key points can be mentioned as
follows. Glass Hamilton syringes (5 ml) have been used for
the sample delivery (maximum operating pressure 200 psig/
15 bar) while, under the described conditions, the pressure
in the system is expected to be 30–60 bar (Eq. (2), also see
Fig. 1). The reacting sample has been delivered to the
cryomedium as a small-diameter high-speed free-flowing
jet (f 50–60 Am diameter, f 50–70 m s 1 velocity).
However, any slow-down/break-up of the jet due to air
resistance that leads to an increase of the delivery time has
not been considered. In addition, cooling of the jet due to
heat exchange with air in the vicinity of the rapidly rotating
cold plate/LN2 surface has not been evaluated (f 1 krpm
rotation speed, < 1 cm distance). This factor plays an
important role in decreasing the jet temperature to f 8 jC
in our freeze-quench setup, even though we have two- to
fourfold faster jets. Tanaka et al., as well as other researchers
that develop ultrafast freeze-quenching devices [146], use
the metmyoglobin–azide reaction as the molecular timer to
calibrate the freeze-quench instrument. However, a f 10-
fold decrease of the apparent binding rate constant at high
azide concentrations (>1 mM, Tables 2 and 3) is not taken
into account, as well as the slow-down of the binding
reaction due to decrease of the jet temperature. Both of
these factors lead to ‘‘underreaction’’ of the freeze-quench
sample, resulting in the apparent ‘‘shortening’’ of theglobin with azide at pH= 5 and 20 jC
k 1
app, s 1 1.43F 0.03
EA
 1, kcal/mol DS 1
# , cal deg 1
mol 1
16.9F 0.4  2.3F 1.4
k 1
app, s 1 4.3F 0.6 102
EA
 1, kcal/mol DS 1
# , cal deg 1
mol 1
18.8F 1.5 15.6F 5.4
A.V. Cherepanov, S. de Vries / Biochimica et Biophysica Acta 1656 (2004) 1–316sample-ageing time. In addition, the pH of the metmyoglo-
bin–azide reaction mixture in the assay, a critical value that
defines the binding rate constant, has not been specified.
Finally, Tanaka et al. use a single freeze-quench sample for
the determination of the instrument ‘‘dead’’ time.
In our opinion, the real ‘‘dead-time’’ of the freeze-quench
instrument reported in [144,145] is between 0.8 and 1 ms,
which is nevertheless a five- to sixfold improvement in time
resolution with respect to the ‘‘Ballou’’ design.
Decreasing the distance between the mixer and the
cryomedium allows an additional improvement of the time
resolution of the freeze-quench set up, which, similar to
increasing the linear flow rate, requires a major redesign of
the instrumental setup. Use of a liquid medium (i.e. iso-
pentane) for cryofixation at high jet velocities (f 50–200
m s 1) poses a limitation of lf 2 cm on the distance
between the mixer and the cryomedium. Freeze-quenching
at shorter distances yields inhomogeneous sampling due to
‘‘splashing’’ of the cryomedium during spraying, nozzle
blockage and freezing of the sample in the mixer. It appears
a prerequisite to use a solid cryomedium in order to decrease
the transport distances and the delivery times to 2–3 mm/
30–40 As (Fig. 1). Cryofixation on a cold plate gives rise to
several technical problems that involve rotation of the cold
plate, actuation of the mixer, and delivery of the rotation
motion into the vacuum chamber. We have designed and
assembled a prototype cold-plate MHQ instrument (A.
Cherepanov and S. de Vries, unpublished); the character-
ization of the device, optimization of the quenching con-
ditions, and determination of the sample-ageing time are
currently in progress.
In this work, we use isopentane as the cryomedium, so
the minimal transport distance is set to 20F 2 mm. The jet
velocity is high, < 200 m s 1; thus, the minimal overall
sample transport time is f 100 As (Fig. 1, Table 1).
2.1.3. Freeze-quenching
Two main parameters determine the kinetics of the
freezing process, the speed of the sample jet, and the jet
diameter [147].
It was previously shown that the spraying of fast jets
(f 200 m s 1) of small diameters (10–20 Am) into a
liquid cryomedium (isopentane at 120 K) [148] results in
cooling rates of at least 3 106–107 deg s 1 (based on
calculations in Refs. [149,150]). Under these circumstan-
ces, water does not have time to form a crystal lattice, and
vitrifies to the amorphous solid water (ASW), bypassing
the liquid–ice phase transition [147,148]. In terms of its
structure, metastable ASW is directly related to liquid water
[151–156], and, at a temperature of approximately 130 K it
undergoes a reversible, thermodynamically continuous liq-
uid– liquid transition [157], forming a highly viscous,
deeply metastable supercooled extension of normal liquid
water [158–160], which crystallizes only on warming to
f 160 K [161,162]. Vitrification of samples is widely used
in cryobiology for (a) tissue storage and cryopreservation,and (b) preparation of samples for electron microscopy, to
avoid structural damage of the biological specimen due the
expansion of the aqueous phase during the liquid–ice
phase transition [163–166].
In the present work, we followed the vitrification con-
ditions described in Ref. [148], to ensure that the sample is
freeze-quenched within f 30 As after it contacts the cry-
omedium. In comparison, the cryofixation time of the
conventional freeze-quench setup is almost 100-fold longer,
f 2 ms [51]. The general reasons for that are, (i) a 10–20-
fold larger diameter of the sample jet (0.3–0.4 mm), and (ii)
an order of magnitude lower jet velocity (1–10 ms 1). Both
of these factors seems to limit the heat transfer rate from the
cryomedium to the sample droplets.
Summarizing the strategy of improving the time reso-
lution of the freeze-quench process, in the present work we
attempted (a) to minimize the mixing time, (b) to minimize
the sample transport time, and (c) to increase the heat
transfer rate during cryofixation. Along these lines of
consideration, the following modifications have been in-
troduced in the design of the freeze-quench instrument: (a)
the mixer dimensions were scaled down, (b) the opera-
tional pressure was increased, and (c) the sample-delivery
tubing was omitted.
2.2. Description of the MHQ setup
In the current setup (Fig. 2), the sample exits the mixer as
a free-flowing jet of a small diameter (f 20 Am) (Fig. 2-
4,5). Depending on the volumetric flow rate, the jet speed
can reach values up to f 200 m s 1.
The sample is injected into the mixer through the
high-pressure sample injection valve (Rheodyne type)
using the HPLC-type solvent delivery pumps with oper-
ational pressures between 1 and 415 bar (14–6000 psi)
(Fig. 2-12, 13-1,13-2).
To minimize the slow-down and break-up of the jet at
linear flow rates above 20 m s 1, both mixer and cryome-
dium are mounted inside a low pressure chamber (Fig. 2-1),
which is operated at pressures 0.5–100 mbar (Table 1). Low
pressure ensures that the jet speed is constant along the
distance between the mixer and the cryomedium.
The characteristic feature of the novel freeze-quench
device is a continuous-flow modus operandi. It stems from
the necessity to carry out the consecutive sample-prepara-
tion events in a reproducible way. A dry start of the
sample flow under vacuum results in the eventual clogging
of the orifice, sometimes even before injection of the
sample. This is another reason, besides the high-pressure
requirement, why the sample delivery has been changed
from the pulsed-flow-type to the HPLC-type injection
mode.
After injection, the reaction sample is sprayed into the
vial (Fig. 2-7) containing cold isopentane at 125 K. To
ensure homogeneous freeze-quenching, the cryomedium is
stirred vigorously with an external magnetic stirrer (Fig.
Fig. 3. Schematic drawing of the novel tangential micro-mixer. 1—Mixer
body; 2—platinum inlay with the orifice; 3—brass screw-in cap. Reaction
components A and B enter the mixer body as indicated; they are filling the
mixing volume passing through four channels arranged in the cross
geometry, in which each channel is offset with respect to the opposite one
for half-width of the channel. Components are forced through a narrow
orifice in the platinum inlay and the opening in the brass screw-in cap into
the low-pressure chamber.
Fig. 2. Schematics of the freeze-quenching setup. 1—Low-pressure
chamber; 2—stainless steel rod holder; 3—90j bracket holder; 4—
tangential micro-mixer; 5—sample jet; 6—solvent collection vessel; 7—
sample collection vessel; 8—magnetic stirrer; 9—low-pressure chamber
base plate; 10—LN2-cooled vapor trap; 11—5-Am and 0.2-Am in-line
solvent filters; 12—Rheodyne-type sample injection valves; 13-1, 13-2—
HPLC-grade solvent delivery pumps; 14—carrier solvent vessel; 15—RV5
oil vacuum pump; 16—compressed Ar gas vessel. All fluid and gas
transport lines are equipped with HPLC-grade PEEK tubing and high-
pressure ferrule connections (15 kpsi). The carrier-solvent vessel (14) is
purged with Ar (16) to maintain anaerobic conditions. Two HPLC-grade
pumps (13-1, 13-2), installed in parallel, are used to deliver the carrier
solvent to the micro-mixer (4), bypassing the ‘‘enzyme’’ and ‘‘sample’’
injection valves (12). The solution enters the low-pressure chamber (1) as a
free-flowing jet (5). In the purging mode, the jet is collected in the solvent
collection vessel (6). In the operation mode, the reaction sample is sprayed
into the sample collection vessel (7), filled with cold isopentane (150 K).
During collection, the isopentane is vigorously mixed by the magnetic
stirrer (8). To initiate the collection of the sample, the swinging arm (3) is
rotated in the low-pressure chamber by an external magnet. For further
comments, see text.
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both the jet velocity and the jet length. After freeze-
quenching of the sample, the isopentane-sample slurry is
transferred to the cold bath equilibrated at 125 K. The
slurry is used for the analysis by low temperature optical
absorbance spectroscopy without additional treatment. For
X-band EPR spectroscopy, the sample suspension is
concentrated and packed in the EPR tube in a cold
centrifugation setup (see Experimental procedures).
In summary, the reaction chemistry is initiated in a four-
jet tangential micro-mixer. The mixed solution is injectedinto a low-pressure chamber as a high-speed free-flowing jet
of a small diameter. The components react while the jet
travels from the mixer to the surface of the cryomedium,
where the reaction intermediates are captured after a sudden
freezing of the reaction sample. In the present work, samples
are analyzed by low temperature optical absorbance spec-
troscopy, or X-band EPR spectroscopy.
2.3. Principle, design, and dimensions of the novel four-jet
tangential micromixer
The principle of a novel four-jet tangential mixer is based
on earlier designs reported in [49,50,132,140,143] (Fig. 3).
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(arranged in a X-form geometry), which are leading the
reaction components to the pre-mixing chamber positioned
in the middle of ‘‘X’’ (Fig. 3-1). The opposite channels are
offset in respect to each other by the half-width of the
channel, so that the liquid streams are pre-mixed with a
resulting angular momentum at relatively low Reynolds
numbers (Re < 1000). After pre-mixing, the four-stream
solution is forced through a narrow orifice (Figs. 3-2 and
4-I-3) to the sample delivery tube [49,50,132], or, in our
setup, directly into the low-pressure chamber, in a direction
perpendicular to the plane of the channels. The solution in
the orifice is accelerated to a high linear velocity, and the
mixing of the reaction components takes place at moderate
Reynolds numbers (Ref 4000).
Compared to the ‘‘Ballou’’ design, the distinguishing
feature of the novel mixer is an alternating sequence of the
sample channels (ABAB versus AABB, see Fig. 3-1),
which provides high mixing efficiency of the reaction
components. In addition, the dimensions of the mixer are
scaled down roughly 10-fold. For example, the channels
leading to the pre-mixing chamber are 60F 5 Am wide and
of similar depth. The pre-mixing chamber is approximately
rectangular with dimensions 120F 10 120F 5 60F 5
Am (Figs. 3 and 4-I,II). The flat surface, which bears the
engraved channels and pre-mixing chamber, is covered
with a 100-Am-thick platinum inlay with an orifice in
the middle (Fig. 3-2). When the inlay is mounted inside
the mixer head (Fig. 3-1), the orifice is positioned opposite
to the center of the pre-mixing chamber. The orifice
geometry is depicted in Fig. 4-I. It has a cylindrical shapeFig. 4. Images of the micro-mixer, and the geometry of the (pre)mixing chamber.
the two channels (4) (A–A, or B–B, see II). The pre-mixing chamber (3) is con
in the platinum inlay cover. (II)—Dismounted mixer showing the channels and th
The components enter the pre-mixing chamber through the channels in the altern
and the brass holder) in the operating mode.with a diameter of 20F 1 Am and a length of 33F 1 Am,
providing a mixing volume of f 10 pl. The solution
enters the orifice through a cut-conical area with a depth
of 67F 1 Am and a diameter of approximately 100 Am.
Together with the indentation in the mixer body, it forms
the walls of the pre-mixing chamber (Fig. 4-I-3), which
has a volume of f 1 nl (Table 1).
The platinum inlays with different orifice diameters,
i.e. 5, 10, 20, 30 50 and 100 Am are commercially
available. We are using primarily inlays with a 20-Am-
orifice, which is the most versatile for use, giving stable
backpressure and low clogging frequency during sample
injection and/or short-term storage in the assembled state
(up to 3 days).
The platinum inlay is secured on the top of the mixer
head with a brass screw cap (Fig. 3-3). It has a 0.3-mm-wide
orifice in the middle, which allows the jet to exit the mixer
(Fig. 4-III).
2.4. Estimation of the duration and the efficiency of mixing
2.4.1. Mixing time
Chemical reaction initiated in the mixing-and-sampling
instrument starts in the course of micromixing of the
reaction components [167,168]. In relation to the tangential
mixer, it is important to understand whether this process
takes place already in the pre-mixing chamber, or in the
orifice, where the solution is accelerated to a high linear
velocity. It is essential to pinpoint the mixing place,
because the resulting sm value could differ roughly by
two orders of magnitude. For example, if the reaction(I) The slice through the mixer body (5), and the platinum inlay (2) along
fined between the indentation in the mixer body, and the narrow orifice (1)
e pre-mixing chamber. Letters relate to the two-component-mixing, A +B.
ating way (ABAB). (III)—Assembled mixer (with mounted platinum inlay
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volume) at the Reynolds numbers Ref 500–1000, the
sample-mixing time is sm = 18 As at 3.4 ml min 1 flow
rate. On the other hand, if the mixing occurs in the orifice
(f 10 pl volume), the sample-mixing time at the same
flow rate is much shorter, smf 180 ns, and the Reynolds
number is higher, Ref 4000.
We have sufficient data showing that the mixing of the
reaction components does not occur in the pre-mixing
chamber, and the sm values are confined to the (sub)micro-
second domain according to the calculations above. Detailed
studies on the mixer characterization and determination of
the mixing time are to be published as a separate paper
elsewhere.
2.4.2. Mixing efficiency
The efficiency of mixing has been assayed by measur-
ing the extent of a diffusion-limited reaction as a function
of the solution viscosity. The protonation of 2-hydroxycin-
namic acid (2-HCA) has been used for this purpose. In
general, the rate constant of proton transfer ranges be-
tween f 108 and 1011 M 1 s 1, and for a small organic
molecule such as 2-HCA it is around 5 1010 M 1 s 1Fig. 5. Two-component liquid mixing in the novel tangential micromixer:
quenching of the 2-HCA-fluorescence emission by HCl. 0.2 mM 2-HCA,
pH= 9.2 was mixed with 10 mM HCl to induce a pH-jump and protonate 2-
HCA. Images of the jet were taken f 0.8–1 mm away from the orifice of
the micro-mixer (at 4–5 As after mixing). (A) Fluorescence emission of the
0.2 mM 2-HCA mixed with water. (B) Quenching of the fluorescence
emission of 2-HCA after mixing with HCl. (C) Dark count: fluorescence
emission of water recorded under conditions identical to above. The jet was
visualized as described in Experimental procedures.
Fig. 6. Efficiency of mixing in the novel tangential micro-mixer as function
of the solution viscosity of the reaction component (2-HCA). The efficiency
of mixing was calculated from multiple series of the fluorescence emission
images (similar to the images shown in Fig. 5) as described in Experimental
procedures. The second top axis (solution viscosity) was calculated from
the glycerol content using Eq. (3) with the empiric coefficients A=
2.29 10 2, and B= 6.94 10 3. The top axis showing the protein
concentration was calculated from the solution viscosity values taking
A= 2.718 10 3 m3 kg 1, and B= 1.842 10 3 m3 kg 1, as determined
for lysozyme at 35 jC in Ref. [172].[3]. In the case of 2-HCA, the protonation is accompanied
by a characteristic quenching of the fluorescence emission
at 493 nm, so the extent of the reaction can be monitored
accordingly (Fig. 5). To vary the viscosity, glycerol was
added to the 2-HCA solution in increasing amounts, and
the mixing with HCl was assayed as described in Exper-
imental procedures. The results are shown in Fig. 6. The
mixing efficiency is f 100% at 0–35% glycerol, decreas-
ing to f 50% at 60% glycerol. The viscosity values that
correspond to the glycerol concentrations used are shown
on the second top axis of Fig. 6. On the top axis, the
‘‘protein concentration’’ values are displayed that corre-
spond to the viscosity of the solution. The former were
estimated using Einstein’s basic analysis of the dependence
of the relative viscosity on the concentration of rigid
spherical particles [169,170], extended to suspensions of
high particle concentrations [171], and further adapted for
protein solutions [172,173] (Eq. (3)).
gr ¼ exp
Ac
1 Bc
 
ð3Þ
gr is the relative viscosity gr = g/go; g and go denote the
viscosity of the solution and the solvent, respectively, c is
Fig. 7. ‘‘Biphasic kinetics’’ of metmyoglobin–azide binding reaction: the
[N3
1]-dependent change of the observed rate constant values. The binding
reaction was studied in the stopped-flow instrument at 5 jC. Horse heart
metmyoglobin was mixed with sodium azide solution resulting in 11 AM
MbFe3 +, and 13.41 AM, 27.53, 53.39, 108.7, 205.3, 406.3, 836.4 AM,
1.653 mM, 3.173, 6.52, 12.95, 25.38, 50.76, 101.63, 199.56, and 395.69
mM N3
1 at pH= 4 (crossed squares); 19.63 AM, 39.07, 75.39, 153.54,
295.43, 573.5 AM, 1.19 mM, 2.343, 4.703, 9.417, 18.48, 35.36, 66.82,
136.25, and 273.2 mM N3
1 at pH= 5 (open circles); 22.72 AM, 44.71,
89.02, 172.9, 336.1, 658.4 AM, 1.276 mM, 2.547, 4.964, 10.19, 20.73,
41.09, 76.65, 148.2, 288.6, 538,6 mM and 1 M N3
1 at pH= 5.5 (closed
circles). Prior to the stopped-flow shots at pH = 5 and 5.5, both
metmyoglobin and azide were pre-equilibrated to the appropriate pH in
25 mM Na-citrate buffer. At pH= 4, metmyoglobin was dissolved in water,
and mixed with the pH-pre-equilibrated azide, triggering both pH-jump and
binding of azide to the protein. The values of the observed rate constant
were determined by fitting the exponential fitting function to the stopped-
flow traces. The dotted traces on the lower graph were computed by fitting
Eq. (5) to the experimental data.
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experimentally determined for concentrated lysozyme sol-
utions at 35 jC, A= 2.718 10 3 mg 1 ml, and B =
1.842 10 3 mg 1 ml.
From Fig. 6 it follows that the micro-mixer is capable of
efficient mixing of protein samples with concentrations up
to 250 mg ml 1. For lysozyme (chicken egg-white,
Mwf 14.3) this corresponds to f 18 mM protein. Thus,
the novel micro-mixer can be considered as an excellent tool
for the preparation of pre-steady samples for detailed
spectroscopic structure analyses, which require concentrated
protein samples (f 1 mM).
2.5. Model system to determine the minimal sample-ageing
time
The binding of azide (N3
1) to metmyoglobin from horse
heart (MbFe3 +) was used as a molecular timer to charac-
terize the mixing and freeze-quenching properties of the
novel setup. This choice of the reaction system allowed us
to analyze freeze-quench samples using low-temperature
optical absorbance spectroscopy and X-band EPR spectros-
copy. In retrospect, the disadvantages of the reaction couple
MbFe3 +–N3
1 are (a) the unexpectedly slow kinetics at
high azide concentrations, and (b) the complex binding
mechanism, both phenomena not noticed before [174–
177] because the time scale of these studies was in the
millisecond time domain.
The binding rate of azide is known to increase at low pH
Fig. 7, lower graph, Table 2) [178]. On the other hand,
metmyoglobin tends to (partially) precipitate at pH < 5
within minutes of storage. For our analysis we chose the
pH = 5.0, when metmyoglobin is stable in solution for hours
(not shown).
To characterize the reaction between MbFe3 + and
N3
1, we performed a pre-steady state kinetic analysis
in a stopped-flow instrument. Analysis of the kinetic
traces recorded at different azide concentrations displayed
an unusual, two-rate-constant kinetic behavior (Fig. 7)
that resembles the kinetic data obtained for the ferric
haemoproteins from other sources [179]. The second-
order rate constant for azide binding calculated from
observed relaxation times at different azide concentrations
is roughly 10-fold higher at [N3
1 ] < 1 mM than at
[N3
1 ]>10 mM. The rate constants are only weakly
dependent on the ionic strength of the solution, in
agreement with previously reported data [178]; addition
of 0.8 M NaCl leads to a decrease of the binding rates at
both ‘‘high’’ and ‘‘low’’ [N3
1] of < 20% (not shown).
The ratio between the kobs values at ‘‘low’’ and ‘‘high’’
[N3
1] is pH-dependent: it is the highest at low pH (kobs
low/
kobs
highf 16 at pH= 4, see Table 2), while, at pHf 7 it
approaches unity: the binding becomes essentially
‘‘monophasic’’ [174,175,177].
In our opinion, and in agreement with similar proposals
availing in the literature [179–183], the reaction between
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ing reaction scheme.
The binding of azide occurs as a displacement of the
water/hydroxyl/hydroxonium molecule at the hexacoordi-
nated heme iron. The binding reactions (4–5, 4–6) are
proposed to occur under the conditions when d[4MbFe3 +]/
dtf 0, because the equilibration between water and
myoglobin is faster than the subsequent binding of a
ligand [184]. Based on simple electrostatics, one would
expect that the rates of water-myoglobin equilibration
increase in the sequence 3–4 < 2–4 < 1–4. The slowest
is the dissociation of OH1, followed by the dissociation
of H2O; the dissociation of the hydroxonium ion H3O
1 +,
supposedly, is the fastest process (H104 s 1). The water-
myoglobin equilibrium is pH-dependent too. With de-
creasing pH, the equilibrium shifts towards the free
4MbFe3 + due to the formation of an unstable
1MbFe3 +H3O1 +. At alkaline pH the equilibrium shifts
towards the water-bound species 2MbFe3 +H2O0 and
3MbFe3 +OH1 . As a result, the concentration of
4MbFe3 + is higher at low pH, leading to an apparent
increase of the azide-binding rate.
At pH= 5 and azide concentrations below 1 mM, the
water-myoglobin equilibration via the routes 1–4 and 2–
4 occurs faster than the binding of azide (routes 4–5 and
4–6). At [N3
1]>10 mM, the rate of binding of azide
exceeds the rate of dissociation of water from the heme
iron (route 2–4); on the other hand, it is still signifi-
cantly slower than the dissociation of 1MbFe3 +H3O1 +
via the route 1–4. This shift of the dynamic equilibrium
leads to an approximately 10-fold decrease of the
4MbFe3 + concentration, causing a f 10-fold decrease of
the apparent binding rate constant (kapp).
The detailed elucidation and verification of this mecha-
nism, however, falls beyond the scope of this paper. For the
purpose of using the myoglobin–azide couple as a molec-
ular timer, a semi-empirical treatment of the reaction mech-
anism was found sufficient. At [N3
1 ]g[1,10] mM, the
reaction is essentially ‘‘monophasic’’ and can be adequately
treated as an associative bimolecular collision,
MbFe3þ þ N13 Z
k
app
1
k
app
1
MbFe3þ  N13The integration of the corresponding differential equation
yields thefollowing analytical solution.
CðtÞ ¼ a 1 e
k
app
1
ct
1 bekapp1 ct ;
where
c ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð½Mb0 þ ½N30 þ Kappd Þ2  4½Mb0 þ ½N30
q
;
a ¼ 2½Mb0 þ ½N30½Mb0 þ ½N30 þ Kappd þ c
;
b ¼ ½Mb0 þ ½N30 þ K
app
d  c
½Mb0 þ ½N30 þ Kappd þ c
; and Kappd ¼
K
app
1
K
app
1
;
[Mb]0, and [N3]0 are the initial concentrations of metmyo-
globin and azide, respectively.
Under the pseudo-first order approximation, [N3]0>>
[Mb]0, Kd
app, the parameters approach c! [N3]0, a! [Mb]0,
b! 0, and the solution reduces to
CðtÞ ¼ ½Mb0ð1 ekobstÞ ð4Þ
where
kobs ¼ kapp1 c ð5Þ
k
app
1 ¼ j
ekT
h
e
DS#1
R e
E1
A
RT ð6Þ
and
K
app
d ¼ e
DS#1DS
#
1
R e
E1
A
E1
A
RT ; ð7Þ
the transmission coefficient j = 1.
In principle, Eq. (5) can be further simplified to kobs =
k1
app[N3]0 + k 1
app.
Fitting of Eq. (5) to the experimental data is shown in
Figs. 7 and 8 (dotted traces). It follows the kobs values
closely when [N3
1]g[1,10] mM.
To complete the empirical characterization, the binding
of azide was assayed at different temperatures, and the
kinetic and thermodynamic parameters were determined at
both low ( < 1 mM), and high (>10 mM) [N3
1], in the wide
range of azide concentrations (20 AM–1.5 M) (Fig. 8A–C).
The values are summarized in Table 3. Using these values,
one can calculate the binding rate at any temperature and
azide concentration (at pH = 5), which appears to be suffi-
cient for the determination of the sample-ageing time of the
MHQ instrument.
2.6. Multi-wavelength analysis and deconvolution of two-
component spectra
In the present work, the extent of binding of azide (N3
1)
to metmyoglobin from horse heart (MbFe3 +) was deter-
mined using both low-temperature optical absorbance spec-
troscopy and X-band EPR. Each freeze-quenched sample
Fig. 8. Temperature-dependence of the kinetic parameters for the azide-metmyoglobin binding reaction determined at pH= 5. A. Variation of the observed rate
constant with [N3
1] measured at different temperatures. Inset: blow-up of the binding data at high azide concentrations. The dotted traces were computed by
fitting Eq. (5) to the experimental data. (B, C) Arrhenius plots for the k1 and k 1 apparent rate constants determined at [NaN3] < 1 mM (B), and [NaN3]>10 mM
(C). The k1
app and k 1
app values were calculated using Eq. (5). The binding reaction was studied in the stopped-flow instrument at pH= 5.04. Horse heart
metmyoglobin was mixed with the sodium azide solution, resulting in 11 AM MbFe3 +, and 19.63 AM, 39.07, 75.39, 153.54, 295.43, 573.5 AM, 1.19 mM,
2.343, 4.703, 9.417, 18.17, 18.48, 26.82, 34.52, 35.36, 47.35, 66.82, 67.98, 106.28, 132.76, 136.25, 189.88, 270.7, and 273.2 mM N3
1. The values of the
observed rate constant were determined by fitting the exponential fitting function to the stopped-flow traces.
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complex MbFe3 +N31 . The corresponding spectra thus
represent a superposition of the electronic absorbances of
these compounds, or their first derivatives in case of EPR. In
each case, the fraction of conversion, or the relative ratio of
[MbFe3 +N31] to the total concentration of metmyoglobin
species, [MbFe3 +]0, depends on the sample-ageing time,
reaction temperature, and [N3
1].
The aim of the procedure below is to deconvolute the
mixed spectra of the freeze-quenched samples into the
individual spectral components, and to determine the frac-
tion of conversion in each case. Deconvolution is con-
fronted by experimental complications arising during the
sample preparation and recording the spectra, as mentioned
below. (i) Sample-to-sample variation of the effective chro-
mophore concentration (EfC) in the cuvette due to the
packing-dilution uncertainty (up to 20–30%). (ii) Sample-
to-sample variation of the baseline slope and absorbance
offset for the independently prepared otherwise identical
samples. (iii) Slightly different spectral characteristics of
metmyoglobin samples prepared by ‘‘slow’’* freezing of
aqueous solutions with respect to ‘‘rapidly’’ freeze-
quenched samples. (*) Slow freezing was carried out by
pipetting 1 ml of sample solution to the cuvette pre-cooled
to 77K).
For the metmyoglobin–azide reaction couple, the first
two points relate to both optical absorbance spectroscopy
and X-band EPR, while the last point appeared relevant for
optical spectroscopy only.
The reason for the variation of the slope and the offset
of the baseline in the optical absorbance spectra mightstem from the inhomogeneity and/or different microstruc-
ture of the isopentane matrix under (a) slightly different
freezing conditions, (b) different packing concentrations of
the ice-sample suspension, and (c) spectrum-to-spectrum
variation of the temperature drift (80–110 K) in the low-
temperature setup during scan averaging. For the analysis
we assumed that these effects yield proportional/linear
baseline shifts between 460 and 710 nm. The following
procedure has been found to give satisfactory deconvolu-
tion results.
(1) Electronic absorbance spectra of the freeze-quenched
samples (Fig. 9A) were baseline-corrected by fitting
with a linear regression in the case of optical
absorbance spectroscopy, or with a weighted high-term
polynomial fitting in the case of EPR (see Experimen-
tal procedures). The residuals of the fitting were taken
for further analysis as the baseline-corrected spectra
(Fig. 9B).
(2) Relative spectral extinctions of the individual compo-
nents, MbFe3 + and MbFe3 +N31, were determined. For
that, pure (one-component) spectra, SP and SS, were
recorded at the same EfC. (SP is the spectrum of the
product, MbFe3 +N31; SS is the spectrum of the starting
material, MbFe3 +). In the case of optical absorbance
spectroscopy, a large number of freeze-quench samples
of MbFe3 + and MbFe3 +N31  (f 50 each) were
prepared starting with the same amount of protein.
The recorded spectra were corrected for the baseline and
averaged to minimize the uncertainty of packing
dilution. ‘‘Slowly’’ frozen metmyoglobin samples could
Fig. 9. Processing of the spectral data. Optical absorbance spectroscopy at 77K (left), and X-band EPR at 18K (right). (A) Raw spectra. Samples
were obtained at different concentrations of sodium azide and at a distance to the cryomedium surface of 6.2 cm. The sample volumetric flow rate
was 2.0 ml min 1 (f 117 m s 1). Final concentrations are [MbFe3 +]—0.73 mM; [NaN3]—4.24 mM, 8.01, 15.62, 31.45, 64.99, 131.1, 243.97,
464.24, 898.58 mM, and 1.415 M, pH= 5. Dotted traces are calculated by fitting a linear regression (left), or a weighted high-term polynomial
function (right) to the recorded spectra. The fitting residuals were used as the ‘‘baseline-corrected’’ spectra shown in (B). Insets show the blow-up
of the high-, or low-spin regions of the spectrum. Eq. (8) was fitted to the ‘‘baseline-corrected’’ spectra in (B); in each case the ‘‘dilution
coefficient’’ of the spectrum was calculated with respect to the spectra of pure compounds SS and SP. The spectra in (C) were normalized to the
same EfC by dividing the spectra in (B) by the ‘‘dilution coefficient’’. The weighted fitting with a polynomial function is described in Experimental
procedures.
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their spectral characteristics differ from the ‘‘rapidly’’
frozen samples in band positions by 2–4 nm and
relative band intensities for 4–6%. In the case of X-
band EPR, the spectra of the ‘‘slow’’ and ‘‘fast’’ frozen
samples were found essentially identical.
(3) Baseline- and EfC-normalized spectra of the individual
components obtained above, SP and SS, were used
further for the deconvolution of the mixed spectra
MbFe3 +–MbFe3 +N31. Given the fact that the totalconcentration of metmyoglobin remains constant during
the reaction, the multivariate function was fitted to each
mixed spectrum as follows.
FitSX ¼ DðSSð1 CÞ þ CSPÞ ð8Þ
FitSX is the fit of the mixed spectrum SX; SS is the
spectrum of MbFe3 + (first variable); SP is the spectrum of
MbFe3 +N31 (2nd variable); D is the fitting parameter—the
Fig. 10. Integrated (time-resolved) product formation trace for the
metmyoglobin–azide binding reaction. The percent of conversion was
calculated by fitting Eq. (8) to the individual spectra (shown in the insert).
The time values on the bottom axis were calculated as described in the text.
Metmyoglobin was mixed with sodium azide at pH= 5 (final concentrations
[MbFe3 +] = 0.73 mM, [NaN3] = 33.29 mM). Solid circles—data obtained at
a volumetric flow rate of 0.6 ml min 1 (f 35 m s 1), and at distances to
the cryomedium surface of 3, 7, 11.8, 16.5, 21, 25.4, and 29.8 cm. Empty
circles—1.6 ml min 1 (f 93 m s 1), the same distances. Crossed
squares—3 ml min 1 (f 175 m s 1), the same distances. The dotted trace
was calculated by fitting Eqs. (4)– (7) to the integrated data, using the
reaction temperature as the parameter (fitted value Ta
fit is shown).
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respect to SS and SP; C is the fitting parameter—the fraction
of conversion for the sample SX. The percentage of conver-
sion C%= 100 C.
Extraction of the ‘‘packing-dilution coefficient’’
allowed us to normalize all mixed spectra to the same
EfC value. The time-resolved spectra of the reaction
between MbFe3 + and N3
1, corrected for the baseline
and normalized for the ‘‘packing-dilution’’, are shown in
Fig. 9C.
Analyses of the fitted spectra, FitSX, yield additional
important information about the formation of transient
intermediates in the reaction. In the case of two-component
conversion SS! SP, the fitting residuals of the mixed
spectrum SX are expected to converge to the instrument
noise. Appearance of the residuals with repeatable patterns
where the signal intensities are dependent on the sample-
ageing time and/or on the concentrations of the reaction
components would indicate the presence of reaction inter-
mediate(s). Even in the case of a seemingly simple
reaction, such as metmyoglobin–azide binding, we have
been able to observe a spectral signature of a transient
intermediate (see below).
In summary, the advantages of the global spectrum
analysis described above are as follows.
(1) It is not necessary to know the effective concentration
of the absorbing species in the cuvette to deconvolute
the mixed spectrum; the relative spectral ratio of the
individual components suffices.
(2) Every data point in the spectrum contributes to the
determination of the percent of conversion and the
packing dilution of the sample.
(3) Analysis of the fitting residuals in Eq. (8) yields
information on the presence of reaction intermediates.
2.7. Estimation of the reaction temperature
The rate of the molecular timer (binding of azide to
HH metmyoglobin) that was used for the determination
of the freeze-quenching time depends on several impor-
tant parameters, such as ionic strength, pH and the
reaction temperature. A chemical reaction in a thermody-
namically opened system (i.e. a free-flowing jet at low
pressure) differs from the reaction in a closed vessel,
because the isothermal approximation is no longer appli-
cable. Direct measurements of the jet temperature showed
that the latter is dependent on the pressure in the low-
pressure chamber, roughly decreasing for f 0.5 deg/100
mbar; some distance-dependence has been observed,
f 0.5 deg cm 1. In addition, the temperature of the jet
drops by f 3–5 jC in the vicinity of the isopentane
surface ( < 5 cm).
The following reasons for the temperature drop can be
envisaged: (a) degassing of the jet, (b) adiabatic expansion
of the dissolved gases (c) evaporation of water from the jetsurface, and (d) cooling of the jet by the vapors of
cryomedium.
To estimate the actual reaction temperature, the binding
of myoglobin and azide was performed at fixed concen-
trations of both components. In this experiment, we varied
the freeze-quenching time, and, consequently, the degree of
conversion by changing the jet speed and the distance
between the mixer and the cryomedium surface. To trans-
form the speed-distance into reaction-time coordinates, the
following assumptions have been made: (a) the mixing time
was taken as the total residence time of the sample in the
mixer (determined from volumetric flow rate and mixer
dimensions); (b) the jet speed was taken 10% higher than
estimated from the volumetric flow rate and orifice diame-
ter, based on direct measurements of the jet speed using
Laser Doppler Anemometry (LDA); (c) based on previous
experimental [148] and numerical studies [149,150], the
sample cooling rate in isopentane was assumed to be
3 106 deg s 1.
The variation in distance and jet speed results in variation
of the reaction times for nearly two orders of magnitude, so
that the overall duration of the binding reaction is well
covered (Fig. 10).
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fit (average* reaction temperature)
value, the analytic solution of the reaction mechanism
(4) was rewritten in its thermodynamic form via DS#, EA
(Eqs. (6) and (7)), and fitted to the experimental data
points. (*Average relates here to the fact that the temper-
ature of the jet is taken constant along the jet length, and
the time/distance-dependent temperature gradient, as well
as the jet speed-dependent variation of the freeze-quench-
ing time are neglected.) The DS#, EA values were taken
from Table 3.
It follows from the fitting that the average temperature
of the jet decreases from 20 to f 8.2 jC at a pressure of
f 150 mbar (Fig. 10).
2.8. Determination of the sample-ageing time
Knowing the value of the average reaction temperature,
we set out to determine the sample-ageing times at several
different flow rates and jet lengths by varying the azide
concentration. Five different sets of values of the jet speed
and the jet length were chosen to demonstrate the dynamic
range of the MHQ instrument in the microsecond time
domain. For determination of the instrument ‘‘dead-time’’
the maximal jet speed was 187 m s 1, which is very close to
the maximum attainable with the HPLC pumps with the
backpressure limit of 400 bar. The minimal jet length was
f 20 mm. The calculated sample-ageing time for this jet
speed/length combination is sa
calcf 134 As. For the reaction
time of sa
calcf 2.4 ms, the jet length was taken as f 28 cm
and the speed was 117 m s 1. The other three sets had
intermediate values, yielding the sample-ageing times be-
tween 134 As and 2.4 ms.
For each sa
calc value, the optical absorbance spectra of
metmyoglobin/azide mixtures obtained at different azide
concentrations are shown in Fig. 11A–D. All spectra
were corrected for the baseline offset, and normalized for
the packing dilution. In the lower graph the sample-to-
sample variations of EfC values with respect to the pure
spectra SS and SP are shown. SS and SP are also included
in the top graphs in each series of the spectra. It can be
seen that the degree of conversion at a given sa
calc value
increases with increasing of azide concentration in the
reaction mixture, and the exponential [N3
1]-dependent
product formation curves similar to the time-dependent
curve shown in Fig. 10 can be constructed (Fig. 12). For
each data point of the curve, the percent of conversion
was calculated by fitting the Eq. (8) to the mixed spectra
of the relevant MHQ sample; the fitting residuals are
shown below each series of spectra in Fig. 11. At long
reaction times (as in C and D) and high [N3
1], the
residuals show a consistent deviation from linearity
around 580–582 nm, indicating a red shift of the a-band
of the low spin MbFe3 +N31 complex. The reason might
stem from denaturation/precipitation of metmyoglobin at
low pH and high azide concentrations [178], a process
that is too slow to interfere with the binding reactionbetween 0.1 and 0.5 ms, but is apparent on the 0.5–2.5-
ms time scale.
Fig. 12 illustrates the time-resolving power of the mod-
ern pre-steady state mixing-and-sampling techniques, such
as stopped-flow/freeze-quench and MHQ. The dynamic
range of the stopped-flow/freeze-quench covers the sec-
onds-to-milliseconds time scale, while MHQ takes it over
from milliseconds to microseconds.
To plot the stopped-flow and MHQ data on the same
format, the stopped-flow traces are shown as the [N3
1]-
dependent product formation curves recorded at a fixed
reaction time. For that, time-dependent absorbance traces
were acquired in the stopped-flow instrument at 16 different
azide concentrations. Eight values of the reaction times were
chosen, ranging between sa
calc = 2.7 s and sa
calc = 8 ms, and
the percent of conversion was calculated for each trace at
each reaction time. For each sa
calc value, the calculated
values of percent of conversion were plotted versus the
azide concentration (Fig. 12, traces 1–8, open circles). The
stopped-flow experiments were performed at 4.8 jC as
described in Experimental procedures.
MHQ traces obtained at fixed jet speed (f 117 m s 1)
and different jet lengths (2–29 cm) are shown with solid
circles (traces 9–13). Trace 13 was obtained at the maximal
flow rate of 3.2 ml min 1 (187 m s 1) and the minimal
distance of 20 mm yielding the shortest reaction time.
Each trace in Fig. 12 corresponds to a different sa
calc
value. From left to right of the graph, the sample-ageing
times span the range from 2.7 s at low azide concentrations
(0.02–1 mM, trace 1) to 2.4 ms in the middle (1–100 mM,
trace 9), and to 134 As at high azide concentrations (100
mM–2 M, trace 13).
To extract the fitted values of the sample-ageing time, sa
fit,
the following equation was fitted to the experimental data in
Fig. 12.
FitCp ¼ Aþ Bek
High
obs
sfita þ CekLowobs sfita ð9Þ
kobs
Low is the observed rate constant as in Eqs. (4)–(6) at
[N3
1] < 1 mM and 8.2 jC, kobs
High—ibid. at [N3
1]>10
mM; A, B, C, and sa
fit are the fitting parameters. Using
this equation we assume that at a given reaction time the
binding of azide to metmyoglobin is a sum of two
parallel and independent reactions, i.e. one with a high
rate-constant, designating binding at ‘‘low’’ [N3
1] ( < 1
mM), and one with a low-rate-constant binding at ‘‘high’’
[N3
1] (>10 mM), with the rate constants summarized in
Table 3.
The fitted sa
fit values are shown in Table 4. For the
stopped-flow data the sa
calc values were determined (Tables
2 and 3) and serve as a control for the validity of the
‘‘biphasic’’ fitting assumption (9). It can be seen that the
deviation between the fitted and calculated values is small,
falling within 4–7% of the sa
calc value. In the ‘‘transition’’
range of azide concentrations, between 1 and 10 mM, the
deviation increases to 20% (Fig. 12, traces 6–10, Table 4).
Fig. 11. Baseline-corrected and EfC-normalized 77K optical absorbance spectra of the metmyoglobin–azide MHQ samples. Samples were obtained at different
concentrations of sodium azide and distances to the cryomedium surface. The sample volumetric flow rate was 2.0 ml min 1 (f 117 m s 1). (A) Samples
were sprayed in the cryomedium from a distance of 2.3 cm. Final concentrations are [MbFe3 +]—0.73 mM; [NaN3]—4.24 mM, 8.01, 15.62, 31.45, 64.99,
131.1, 243.97, 464.24, 898.58 mM, and 1.415 M, pH= 5. (B) The distance is 6.2 cm. (C) 12.1 cm. (D) 28.4 cm. Eq. (8) was fitted to each reaction mixture
spectrum, employing the spectra of the pure compounds MbFe3 + (SS) and MbFe
3 +N31 (SP) as the independent fitting variables (spectra are shown in the
graphs). The ‘‘dilution coefficient’’ fitting parameter D is shown in the four lower graphs. The [NaN3]-resolved product formation curves calculated from the
‘‘percent of conversion’’ C% (see Eq. (8)) are shown in Fig. 12. The residuals of the fitting are shown below each series of the spectra.
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low rate constant are of the same order of magnitude, and
the difference between the exponential coefficients of the
double exponential fitting function (Eq. (9)) is small. Thisgenerally causes the least-square fitting algorithms to give a
higher uncertainty for fitting parameters.
In parallel to the low-temperature optical absorbance
spectroscopy, a series of MHQ samples has been analyzed
Fig. 13. Baseline-corrected and EfC-normalized X-band EPR spectra of the
metmyoglobin–azide MHQ samples. Samples were obtained at different
concentrations of sodium azide and distance to the cryomedium surface of
6.2 cm. The sample volumetric flow rate was 2.0 ml min 1 (f 117 m
s 1). Final concentrations are [MbFe3 +]—0.73 mM; [NaN3]—4.24 mM,
8.01, 15.62, 31.45, 64.99, 131.1, 243.97, 464.24, 898.58 mM, and 1.415 M,
pH= 5, with the spectrum 1 corresponding to 4.24 mM NaN3. Eq. (8) was
fitted to each reaction mixture spectrum, employing the spectra of the pure
compounds MbFe3 + (SS) and MbFe
3 + N3
1 (SP) as the independent fitting
variables (spectra are shown in the graphs). The [NaN3]-resolved product
formation curve calculated from the ‘‘percent of conversion’’ C% is shown
in Fig. 14. The residuals of the fitting are shown below the spectra.
Frequency: 9.23 GHz; modulation amplitude: 1.0 mT; microwave power: 2
mW; temperature: 18 K. Each spectrum is an average of two acquisitions.
Fig. 12. [NaN3]-resolved product formation curves for the metmyoglobin–
azide binding reaction. Open circles (traces 1–8)—data obtained from the
stopped-flow experiments. Closed circles (traces 9–13)—data obtained
from the MHQ experiments. Dotted/solid traces are obtained by fitting Eq.
(9) to the data values, using the sample-ageing time as the fitting parameter
(fitted values are shown in Table 4). The sample-ageing times for traces 1–
13 span from 2.3 s to 137 As. The conversion of the stopped-flow traces
(absorbance vs. time)-format to the (percent of conversion vs. [NaN3])-
format was performed using Eqs. (4)– (7) as mentioned in the text. The
conditions for preparation of MHQ samples were as follows. Trace 9 (sa
calc
f 2.47 ms)—see Fig. 11D; trace 10 (1.07 ms)—Fig. 11C; trace 11 (562
As)—Fig. 11B; trace 12 (227 As)—Fig. 11A; trace 13 (134 As)—Fig. 16A.
Spectra corresponding to the encircled data points are shown in Fig. 16B.
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corrected for the baseline by weighted polynomial fitting as
described in Experimental procedures, and EfC-normalized
as described above. To calculate the percent of conversion,
the normalized mixed spectra (Fig. 13, 1–10) were decon-Table 4
Comparison of the calculated values of the sample-ageing time (sa
calc) to the
fitted values (sa
fit) calculated from Eqs. (3)– (6)
SF MHQ
sa
calcy sa
fit sa
calcz sa
fitb
2.7 s 2.2F 0.06 s 2.47F 0.026 ms 2.07F 0.17 ms
0.9 s 0.87F 0.03 s 1.07F 0.026 ms 0.43F 0.03 ms
0.3 s 0.29F 0.02 s 562F 26 As 233F 12 As
0.15 s 0.14F 0.01 s 227F 26 As 167F 8 As
70 ms 64F 5 ms 134F 26 As 137F 18 As
30 ms 30F 3 ms
16 ms 20F 3 ms
8 ms 9.9F 1.9 ms
y From the time scale of the SX-18 software package.
z Calculated taking into account the values of the volumetric flow rate,
volume of the mixing chamber, jet speed and the uncertainty of the spraying
distance.
b Determined taking Ta
fit = 8.2F 0.2 jC.voluted in two components, SS and SP, using Eq. (8); the
fitting residuals are shown in Fig. 13 (R1–R10). The
calculated trace is shown in Fig. 14, together with the
corresponding trace derived from the low-temperature opti-
cal absorbance measurements. The experimental data points
closely overlap, and the fitted sa
fit values agree within 15%
error.
From Table 4 it follows that the sample-ageing time
decreases with the decrease of the jet length and an
increase of the jet speed. However, at fixed jet speed
(f 117 m s 1) some deviation from the proportionality of
the time-distance correlation can be clearly seen (Fig. 15).
For example, at f 28 cm the fitted sample-ageing time sa
fit
is f 16% shorter than the sa
calc value obtained from Eq.
(1), at f 12 cm it is 60% shorter, at f 6 cm it is f 59%
shorter, at 2.3 cm it is shorter by f 26%, while at 2 cm
and 187 m s 1 the calculated value equals to the estimated
value within the experimental error (Table 4). The reason
stems from the fact that Ta
fit, the fitted average reaction
Fig. 15. Dependence of the sample-ageing time on the jet length at 117 m
s 1 jet speed. Jet length was measured as the distance between the
micromixer and the surface of the cryomedium. sa
calc values were obtained
using the linear flow velocity values determined from the volumetric flow
rate and the orifice diameter, plus the 10% increase of the linear flow
velocity as measured by LDA. sa
fit values were obtained by fitting Eq. (9) to
the traces 9–13 shown in Fig. 12. To show in the graph the sa
fit value for the
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not take into account the distance-dependent jet cooling.
‘‘Overcooling’’ of the sample jet at intermediate distances
leads to ‘‘underreacting’’ of the sample, causing an appar-
ent ‘‘decrease’’ of the sampleageing time. On the other
hand, at long distances and medium jet speeds, (a) the air
resistance at 150 mbar pressure causes a slow-down of the
jet by 10–15%, and (b) expansion of the jet cone leads to
a decrease of jet momentum per unit of surface of the
cryomedium, slowing down the heat transfer during
quenching. Both of these phenomena cause an apparent
increase of the transit time and ‘‘overreacting’’ of the
sample. ‘‘Overreacting’’ due to increase of the transit time
partly counterbalances the ‘‘under-reacting’’ due to over-
cooling, and the fitted values sa
fit approach the calculated
values sa
calc. The effects of overcooling, jet slow-down, and
cone expansion become insignificant at short distances,
when rapid jets are used (20–30 mm, 150–200 m s 1).
Under these conditions, sa
fit and sa
calc converge within
experimental error.
To conclude, at shortest possible distance (f 20 mm)
and the highest jet speed values (f 187 m s 1), the
sample-ageing time comes down to sa= 137F 18 As (trace
12), which can be considered as the ‘‘dead’’ time of the
MHQ prototype presented in this paper.
trace 13, the distance was decreased to 1.25 cm to account for higher jet
speed of 187 m s 1.
Fig. 14. [NaN3]-resolved product formation curves for the metmyoglobin–
azide binding reaction. MHQ samples were obtained at different
concentrations of sodium azide and a distance to the cryomedium surface
of 6.2 cm. The sample volumetric flow rate was 2.0 ml min 1 (f 117 m
s 1). Final concentrations are [MbFe3 +]—0.73 mM; [NaN3]—4.24 mM,
8.01, 15.62, 31.45, 64.99, 131.1, 243.97, 464.24, 898.58 mM, and 1.415 M,
pH= 5. Closed circles—the values obtained from the analysis of the 77 K
optical absorbance spectra. Crossed squares—18 K X-band EPR spectra.
Solid and dotted traces were obtained by fitting Eq. (9) to the experimental
data, using sample-ageing time as the fitting parameter (fitted values are
shown in the graph).2.9. Reaction intermediate in the metmyoglobin–azide
binding reaction
As was mentioned above, reaction intermediates can be
detected in the freeze-quench samples during the two-com-
ponent deconvolution of their electronic absorbance into the
spectra of the ‘‘starting material’’ and of the ‘‘end product’’. If
a third absorbing component is present in the reaction mixture
it will show itself during fitting as non-zero residuals, with the
maximum perturbation corresponding to the wavelengths of
maximal/minimal absorbance of the intermediate. In the case
of the metmyoglobin–azide reaction couple, we were able to
detect the signature of a transient intermediate at the shortest
freeze-quench times (f 137 As, df 20 mm and the jet
speed f 187 m s 1). It appeared as a pronounced deviation
from linearity in the whole absorbance envelope (Fig. 16A).
In Fig. 16B we show the comparison between the spectra of
the ‘‘130 As’’ sample and the similar spectra obtained after
f 430 As (also see Fig. 12, encircled data points). In the latter
case, the myoglobin reacted for longer time but with less
azide present, that is why the degree of conversion is almost
the same. The features can be seen even better after calculat-
ing the difference spectrum [‘‘130 As’’ min ‘‘430 As’’] (Fig.
16C, lower trace), which appears to be very similar to the
fitting residuals of the ‘‘130 As’’ spectrum (Fig. 16C, upper
trace). The transient intermediate is characterized by an
overall decrease of the absorbance at 500–700 nm, 3-nm
blue shift of the charge transfer band at 503 nm, a 2.5-nm red
Table 5
Optical properties of the metmyoglobin, and metmyoglobin– azide
complexes in the a- and h-band spectral region (Figs. 11A–D and 15C)
k, nm
MbFe3 +H2O 503 537 580.5 629.5 643
MbFe3 +N31 transient 500 538.5 578.5 628 646.5
MbFe3 +N31 539.5 571
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a- and h-bands halfway between their position in the spec-
trum of the free metmyoglobin and the spectrum of the
metmyoglobin–azide complex (Fig. 16C, Table 5). The
perturbation intensity reaches approximately 20% of the
overall spectral intensity at an azide concentration of 759.6
mM (Fig. 16A). The observed azide binding rate at thisFig. 16. Formation of the transient reaction intermediate in the course of the
metmyoglobin–azide binding reaction and its spectral characteristics. A.
Baseline-corrected and EfC-normalized 77 K optical absorbance spectra of
the freeze-quenched metmyoglobin–azide reaction samples, obtained at a
spraying distance of 2 cm, and a sample volumetric flow rate of 3 ml min 1
(f 175 m s 1). Final concentrations are [MbFe3 +] = 0.73 mM; [NaN3]—
30.21, 57.03, 109.9, 212.3, 395.3, and 759.6 mM, pH= 5. Eq. (8) was fitted
to each reaction mixture spectrum, employing the spectra of pure
compounds SS and SP as the independent fitting variables. The residuals
of the fitting are shown below the spectra. (B) Normalized spectra of the
reaction samples prepared at a similar percent of conversion. ‘‘0.43-ms’’
spectrum was obtained from the reaction sample, which was prepared by
mixing the components to the final concentration of [MbFe3 +] = 0.73 mM,
and [NaN3]—243.97 mM, pH= 5 and spraying from the distance of 6.1 cm
with the volumetric flow rate of 2 ml min 1 (f 117 m s 1). ‘‘0.13-ms’’
spectrum was obtained from the sample prepared at the conditions as
follows: [MbFe3 +] = 0.73 mM, [NaN3]—759.64 mM, pH= 5, distance
d= 2.0 cm, the volumetric flow rate of 3.2 ml min 1 (f 186 m s 1). The
values for the percent of conversion for these samples are encircled in the
Fig. 12. (C) Upper trace—residuals of the fitting of the Eq. (8) to the 0.13-
ms sample shown in (B). Lower trace—the difference spectrum [0.13 ms
minus 0.43 ms].[N3
1] can be estimated as kobsf 3.58 103 s 1 at 8.2
jC, suggesting that the intermediate decays with
kappf 1.2104 s 1, i.e. has a half-life time of f 60 As.
2.10. Pre-steady state kinetics of electron transfer in
Escherichia coli bo3 oxidase
Cytochrome c oxidase and cytochrome bo3 oxidase
catalyse the electron transfer from c-type cytochromes and
quinols, respectively, to molecular oxygen. They belong to
the superfamily of haem-copper oxygen reductases [185]
and are evolutionary related to NO reductases [186,187]. In
the physiological sense, haem-copper oxidases serve as
terminal electron acceptors in the bioenergetic metabolism
of all aerobic organisms. These membrane-bound metallo-
enzymes couple electron transfer to proton pumping, there-
by converting the redox free energy DGredox of the overall
reaction in a proton motive force (DAH+), which can be used
to drive ATP synthesis or to transport ions, metabolites and
macromolecules, see, e.g. Ref. [188].
The overall reaction of cytochrome c oxidase and
cytochrome bo3 oxidase is given by the following reaction
(Eq. (I))188).
4cyt:c2þ=2QH2 þ 8HþC þ O2 ! 4cyt:c3þ=ð2Qþ 4HþP Þ
þ 4HþP þ 2H2O ðIÞ
The highly complex molecular mechanism of action of
heme-copper oxidases—involving at least 13 elementary
steps—has been the focus of attention of many researchers
for more than seven decades. We do not intend here to
survey the literature but refer the reader to recent reviews on
oxidases and the references therein [189–195].
The crystal structures of several oxidases are now avail-
able [196–202]. The structural information supports the
picture obtained from a wealth of bioenergetic experimen-
tation that protons (8 HC
+) and electrons (4 cyt. c2 +/2 QH2)
enter the oxidase from different sides of the membrane (see
Eq. (I)), protons coming from the cytoplasm (mitochondrial
matrix) and electrons from the periplasm (inter membrane
space). The quinol substrate protons (HP
+) are not trans-
located, so, although the measured proton/electron ratio (H+/
e) equals 2 and 1 for quinol and cytochrome c oxidases,
respectively, the true number of translocated charges is the
same (q/e = 2). For both types of enzymes, four cytoplasmic
protons (4 Hc
+) combine with four electrons at the binuclear
active site yielding water, the so-called chemical protons.
The other four protons are translocated across the mem-
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protons may follow different routes through the enzyme;
see, e.g. Ref. [203]. The measured H+/e may be dependent
on the buffer, but some oxidases, including those from
archaea, may pump less than four protons [204–207]. For
the remainder of the overview, we will focus only on the
kinetics of electron transfer, and will not discuss protonation
reactions.
All oxidases have a similar active site, a binuclear
center consisting of an iron (heme a3 (o3, b3)) and a
copper (CuB) ligated by three histidine residues. One of the
histidine residues is covalently linked to a nearby tyrosine
(YOH, see Fig. 17) and located in the vicinity of heme a3
or o3. The distance between the heme iron and copper is
around 4.5–5 A˚.
The overall cycle of oxygen reduction catalyzed by
oxidases is too rapid to be monitored by conventional
stopped-flow or rapid freeze-quench techniques, about 1
ms at physiological temperatures [208]. To circumvent the
problem of rapid mixing of the reduced enzyme with
dioxygen, two highly elegant techniques were developedFig. 17. Structures of intermediates formed during the reaction of terminal oxidases
reduced bo3 ubiquinol oxidase from E. coli. The reduced binuclear center is repre
Iron of heme b (or a) is shown to the left of the binuclear center. The covalently cr
as YOj. The electrons in the binuclear center that are donated to oxygen are den
reduced) state, the reaction proceeds from R via A and stops at PM. If R represents
PM, PR to F, which is slowly converted (via several intermediates) to the oxidized
the tyrosine radical in the binuclear center in the conversion from PM to PR. Whe
reduced cytochrome bo3, a radical intermediate is formed within 130 As with optic
assigned to the PM species, because it contains a radical, and, presumably, is forme
heme b with a half time of 400–500 As (Figs. 17 and 18). NB: Specific electron
denoted with large capitals. External input of electrons to the enzyme and corre
transfer from heme b (or a) to the tyrosine radical in the binuclear center is deno
denoted with dotted arrows. Specific protonation and proton translocation events th
the figure. Reaction rates R!A and F!O are taken from Ref. [91] and relate to
PM! {PR, F} were obtained in this study on the bo3 oxidase (Figs. 17 and 18).over the years, the flow-flash method [209,210] and the
triple trapping method [211]. In both techniques partially
or fully reduced cytochrome oxidase is prepared in the
presence of CO. The CO-inhibited enzyme is mixed with
an oxygenated solution creating a metastable state, which
relaxes via ‘‘displacement’’ of CO and oxidation of the
enzyme on seconds-to-minutes time scale. However, before
any appreciable amount of enzyme is oxidized, turnover of
the oxidase is triggered by CO flash photolysis, within
nanoseconds yielding the reduced enzyme ready to react
with dioxygen, thus obviating the need for rapid mixing.
In the flow-flash method, CO-inhibited oxidase and oxy-
genated buffer are mixed in a pneumatically driven mixing
device and the reduction of dioxygen is monitored after a
flash of light using UV–Vis spectrometry [92–95,212–
214]. For resonance Raman spectroscopy, the sample flows
in a small flow cell, and, after photolysis at a particular
spot, the time course of the reaction is followed by
exciting the reacting groups with a (second) laser at
various positions of the cell [215–217]. In the triple
trapping method, which is performed at low temperatureswith dioxygen. Modified from Ref. [91], and adapted for the three-electron
sented by Fe2 + and Cu1 +, denoting heme o3 (or a3) and CuB, respectively.
oss-linked tyrosine–histidine pair is shown as YOH, its neutral radical form
oted with (.). In case when R represents the mixed-valence (two-electron
the fully reduced (four-electron reduced) state, the reaction proceeds via A,
enzyme, O. Heme b (bo3 oxidase) or a (aa3 oxidase) donates an electron to
n R represents the three-electron reduced enzyme, as in quinone-free fully
al properties similar to that of (a mixture of) P and F species, (Fig. 18). It is
d directly from A. PM is converted to PR and/or F by electron transfer from
transfer to the oxygen substrate and corresponding protonation events are
sponding protonation events are denoted in small italics. Internal electron
ted with the dark framed box. Steps that include multiple intermediates are
at are related to the proton-pumping oxidase activity have been omitted from
cytochrome c oxidase; the values < 140 As for A!PM, and < 1.08 ms for
See text for further details.
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the kinetics can be followed by UV–Vis spectrometry
following flash photolysis, and the sample can be
quenched at any time, e.g. frozen in liquid nitrogen and
subsequently monitored by EPR [211,218–221].
For experimentation, the cytochrome c oxidase can be
prepared in either of two states: the fully reduced state
containing four electrons, or the half reduced (mixed-va-
lence) state with two electrons. In addition to that, cyto-
chrome bo3 ubiquinol oxidase can be prepared as a three-
electron enzyme, when it is purified without the ubiquinone
cofactor [222,223].
Fig. 17 summarizes the current view of the initial steps in
oxygen reduction [91,192,224], and in addition includes our
present findings and suggestions. The oxidase (either
mixed-valence, three- or four-electron reduced) initially
resides in the R state, in which the binuclear center itself
already has four electrons necessary for the reduction of
oxygen, two electrons at heme o3 (a3), one electron at CuB
I,
and a hydrogen atom at the tyrosine–histidine pair. Upon
binding of dioxygen in the binuclear center, R is rapidly
converted to the oxygenated intermediate A. The actual
reduction of dioxygen occurs in the next reaction step, when
(a) the donation of a hydrogen atom from the nearby
tyrosine–histidine pair splits the OMO bond, forming the
neutral radical YO*, (b) donation of an electron from CuB
I
results in the formation of the Cu hydroxide, CuB
II-OH, andFig. 18. 77 K optical absorbance spectra of the MHQ samples of cytochrome bo
Spectrum 1—‘‘reduced bo3 oxidase’’—obtained by mixing f 150 AM enzyme sol
phosphate buffer, 0.5 M KCl, pH= 7.5 at a flow rate of 3.2 ml min 1 (187 m s
with 100% O2 saturated buffer at a flow rate of 3.2 ml min
 1 (187 m s 1), d= 20
(152 m s 1), d= 38 mm; spectrum 4—‘‘220 ls sample’’—ibid., d= 53.2 mm;
mixing: f 0.5 mM O2 and f 75 AM bo3 oxidase. The EfC of the enzyme i
acquisitions. Reduced bo3 ubiquinol oxidase was prepared as described in Exp
oxidized bo3 oxidase, diluted to 10 AM in 50 mM K-phosphate, 0.5 M KCl, pH=
cooled cuvette at 77 K within f 30 s after mixing with peroxide. Spectrum 7—
difference of absorbance values in the Soret region and the a-h-band region, the
ageing times were estimated (at 8.2 jC) using the calibration values shown in Ta(c) donation of two electrons from heme o3 (a3) results in
the formation of the oxoferryl complex, FeIVMO. After this
four-electron oxidation step, the enzyme ends in the high-
energy intermediate PM state, in which all of DGredox is
trapped. The name PM originates from the fact that it was
once thought to be a Peroxy intermediate, and it was first
observed in the Mixed valence (two-electron reduced)
enzyme [225]. Currently, there is general agreement regard-
ing the structure of PM. Together with the intermediate A, it
has been first identified by the triple trapping method [211].
Its structure (and that of A) has been confirmed by reso-
nance Raman spectroscopy [215,226,227], showing that PM
represents an oxoferryl state of heme a3, Fe
IV =O. Subse-
quently, a tyrosine radical in the PM state has been identi-
fied, using radioactive iodide labeling of cytochrome c
oxidase followed by peptide mapping [228]. PM is a
transient metastable state; the enzyme relaxes to the resting
oxidized form O via a series of inter/intra/molecular heme–
protein and heme–heme electron transfers and protonation
events. For example, donation of an electron from heme a
(or b) to the tyrosine radical and subsequent protonation
leads to the formation of the PR state, which, after proton-
ation of the oxygen in the CuB
II-OH, yields the reaction
intermediate F. Intuitively, the relaxation kinetics are sup-
posed to be the fastest in the case of the four-electron
reduced enzyme, while in the case of the mixed-valence
enzyme, the PM state, in principle, can be captured under3 ubiquinol oxidase obtained in the course of the reaction with dioxygen.
ution with an anoxic solution of 10 mM ascorbate, 5 AM PES in 60 mM K-
1), d= 20 mm; spectrum 2—‘‘137 ls sample’’—reduced bo3 oxidase mixed
mm; spectrum 3—‘‘190 ls sample’’—ibid. at a flow rate of 2.6 ml min 1
spectrum 5—‘‘1.08 ms sample’’—ibid., d= 253 mm. Concentrations after
n the cuvette is f 3F 0.3 AM. Each trace represents the average of 20
erimental procedures. Spectrum 6—‘‘mixture of P and F-like species’’—
7.5 in the presence of 10 mM H2O2 and frozen by injecting into the pre-
‘‘oxidized bo3 oxidase’’—ibid., in the absence of H2O2. Due to the large
same spectra are shown in two, separately scaled graphs. (*) The sample-
ble 4.
Fig. 19. X-band EPR spectra of the MHQ samples of cytochrome bo3
ubiquinol oxidase obtained in the course of the reaction with dioxygen.
Spectrum 1—‘‘Blank’’—MHQ preparation of anoxic buffer containing 60
mM K-phosphate, 0.5 M KCl, 10 mM ascorbate, and 5 mM PES at
pH= 7.5, freeze-quenched at a flow rate of 3.2 ml min 1 (187 m s 1),
d= 20 mm; spectrum 2—‘‘reduced bo3 oxidase’’—f 150 AM enzyme
solution is mixed with an anoxic solution of 10 mM ascorbate, 5 AM PES in
60 mM K-phosphate buffer, 0.5 M KCl, pH= 7.5 at a flow rate of 3.2 ml
min 1 (187 m s 1), d= 20 mm; spectrum 3—‘‘137 ls sample’’—ibid., but
mixed with 100% O2 saturated buffer at a flow rate of 3.2 ml min
 1 (187 m
s 1), d= 20 mm; spectrum 4—‘‘190 ls sample’’—ibid. at a flow rate of 2.6
ml min 1 (152 m s 1), d= 38 mm; spectrum 5—‘‘220 ls sample’’—ibid.,
d = 53.2 mm; spectrum 6—‘‘1.08 ms sample’’—ibid., d = 253 mm.
Concentrations after mixing: f 0.5 mM O2 and f 75 AM bo3 oxidase.
The EfC of the enzyme in the EPR tube is f 11F1 AM. Spectrum 7—
‘‘mixture of P and F-like species’’—oxidized bo3 oxidase, diluted to 11 AM
in 50 mM K-phosphate, 0.5 M KCl, pH= 7.5 in the presence of 10 mM
H2O2, transferred into the EPR tube and frozen by immersion in LN2
within f 60 s after mixing with peroxide. EPR conditions: Frequency:
9.25 GHz; modulation amplitude: 0.63 mT; microwave power: 2 mW;
temperature: 35 K. NB: To improve the signal to noise ratio each trace is an
average of five EPR spectra recorded under slightly power saturating
conditions.
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intermediates as well, having an extra electron in the
binuclear center (Fig. 17). EPR and ENDOR spectroscopy
of cytochrome c oxidase in the mixed P and F-like state,
performed after equilibration of the enzyme with H2O2,
showed low levels of radical signals ascribed to a mixture of
tryptophan (or cysteine) and porphyrin cation radicals
[229–231], or in case of Paracoccus denitrificans oxidase,
to a tyrosine radical, which most likely does not derive from
the tyrosine–histidine pair [232].
Until the studies reported here, the radicals have been
prepared on a seconds-to-minutes time scale, under (pseu-
do)-equilibrium conditions. In an attempt to follow the
formation of kinetically competent radical intermediates,
we have applied the MHQ technique for studies on the
oxidation of quinone-free three-electron reduced cyto-
chrome bo3 oxidase from E. coli. The preliminary results
are shown in Figs. 17 and 18. Our first data point is obtained
after f 137 As (Fig. 18-2), so the formation of A should be
complete, because it is formed with a rate constant of
3.4 104 s 1 or s1/2 = 20.4 As [223,233,234]. After 137
As, about 50% of the absorbance at 426.5 nm disappears
concomitant with the formation of a peak at 413.5 nm. This
is consistent with oxidation of heme o3
2 + and formation of
the oxoferryl species [223,233]. The intensity at 426.5 nm
decreases only slightly between 137 As and 1.08 ms, while
the peak absorbance maximum at 413.5 nm shifts to 411.6
nm (Fig. 18 (2–5)). A similar spectrum is obtained after
incubation of bo3 oxidase with H2O2, which is a mixture of
oxoferryl P and F states (Fig. 18-6) [229,235–237]. In the
a-band region, a small decrease in absorbance at 556 and
562.6 nm occurs in the first 137 As, consistent with the
oxidation of heme o3
2 +; these small changes are consistent
with a weak spectral contribution of heme o3 in this region.
The absorbance intensity between 545 and 575 nm is
dominated by the split a-band of heme b2 +, and it can be
seen that between 137 As and 1.08 ms, some 20–40% of
heme b2 + is oxidized. In addition, small absorbance changes
are observed around 580 and 631 nm.
For the first time in studies on oxidase catalysis, the
direct reduction of dioxygen observed by EPR spectrosco-
py showed the formation of a transient radical after 137 As,
which decays within 1.08 ms (Fig. 19 (3–6)). The radical
is centered at g = 2.004–2.005, and has an apparent peak-
to-peak width of 1.4 mT; owing to its low concentration,
the signal has to be recorded at saturating microwave
power). At present, the signal to noise is too poor to
assign the radical to a specific amino acid, viz. YO*. The
line shape seems, however, different from the tyrosine
radical observed in Pa. denitrificans oxidase or in 2-
imidazol-1-yl-4-methylphenol, an analog of the tyrosine–
histidine pair [232,238]. The shape is more similar to that
obtained in [229,230,239], but it is not identical. We
cannot conclude at present whether the signal represents
a pure species or a mixture. The signal is also different
from that of the small amount of radical formed in thepresence of H2O2, which has a peak-to-peak width of 1.1
mT (Fig. 19-7). Given (i) the poor signal-to-noise ratio, (ii)
the saturating power used potentially causing changes in
the line shape, (iii) the uncertainty about the spectral
envelope, and (iv) the variations in sample concentration
inherent in the MHQ technique, the concentration of the
radical is estimated at 0.2–0.4 spins per cytochrome bo3.
Because this is similar to the extent of oxidation of heme
b, we propose that the electron from heme b reduces the
radical, consistent with the reduction of PM to the PR state,
or, as earlier suggested to F [223,233].
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containing a tyrosine radical has been previously identified
[228]. Our preliminary data show direct evidence for the
presence of a kinetically competent radical in the case of the
three-electron reduced cytochrome bo3 oxidase as well. The
radical is formed transiently upon oxidation of heme o3 and
it decays following the oxidation of heme b. The optical
absorbance spectra show that the oxoferryl species is formed
concomitantly with the radical; therefore, the radical can be
assigned to the PM reaction intermediate, implying that the
oxidation step A!PM occurs in the case of three-electron
reduced enzyme, similar to the mixed-valence oxidase.
In the case of four-electron reduced cytochrome c oxi-
dase, it was suggested that the reduction of the dioxygen in
the A state leads to the formation of the PR intermediate
[91,192,224,240] bypassing the radical-containing PM state.
However, given the important mechanistic role played by
the tyrosine residue as the donor of the H-atom for the OMO
bond splitting [215,228], it seems unlikely that reduction of
dioxygen would proceed differently in the four-electron
reduced enzyme compared to either two- or three-electron
reduced enzyme. We therefore propose the reaction se-
quence R!A!PM!PR!F to be the compulsory cat-
alytic pathway for all cytochrome oxidases, irrespective of
the oxidation state of the R species. In principle, this
proposal is in agreement with the mechanism of the OMO
bond splitting proposed in Ref. [241]. The fact that PM has
not been observed so far in four electron-reduced cyto-
chrome c oxidase might be due to (a) the identity of the
spectra of the PM and PR states as seen by optical absor-
bance spectroscopy [91,242], and (b) general lack of effi-
cient experimental techniques for detection of short-living
radical species in biological systems.
2.11. Concluding remarks and future prospects
In this review, the development and applications of a
novel microsecond freeze-hyperquenching mixing and sam-
pling methodology—MHQ, have been described. The cur-
rent setup makes it possible to obtain samples with ageing
times in the 100–150 As time domain and analyze them by
low-temperature UV–Vis and EPR spectroscopy. Nontrans-
parent freeze-quenched reaction samples can be analyzed by
low-temperature UV–Vis spectroscopy in the spectral re-
gion above 300 nm, with a resolution of signal intensity of
5 10 3 AU and a spectral precision of 0.5 nm. The high
sensitivity of low-temperature UV–Vis spectroscopy and
the option to acquire multiple scans not only allow detection
of the highly absorbing heme-iron active sites, but also of
sites with lower extinction coefficients, such as iron–sulfur
clusters, copper sites, flavins, non-heme iron centers, diiron
centers, etc.
The improvement in time resolution of mixing, sample
transport, and freeze-quenching processes has been
achieved using a specifically designed four-jet tangential
micro-mixer operating at high pressures c.q. high linear flowrates. Due to the small diameter of the sample jet and high
jet velocity, efficient quenching of the reaction in the MHQ
apparatus occurs in microseconds. The additional specific
benefit of hyperquenching includes maximal preservation of
the structure of the reaction intermediates, of the protein,
protein–protein, or protein–ligand complexes during freez-
ing under vitrifying conditions similar as in cryo-electron
microscopy.
The use of a tangential micro-mixer allows efficient
mixing of concentrated protein solutions; sample delivery
by HPLC pumps gives the possibility to prepare large
amounts of sample (up to 1–2 ml), enabling MHQ to be
used in conjunction with sample-consuming techniques as
FTIR or Mo¨ssbauer spectroscopy.
Even though the characteristic ‘‘dead’’ time of the MHQ
device is more than 35-fold shorter in comparison with the
conventional rapid freeze-quench instruments, several
improvements in time resolution could still be made. About
three times higher linear flow rates (500–600 m s 1, 4–6
kbar) can be used because most enzymes start to unfold/
irreversibly denature only at pressures above 5 kbar [243–
247]. Use of jets with smaller diameters (5–10 Am) can
result in faster cooling compared with f 30 As for a 20-Am
jet. Finally, a major improvement of the time resolution can
be obtained by freeze-quenching the reaction mixture on a
cold plate instead of a liquid cryomedium, because the
sample transport distance can be decreased f 10-fold to 2
mm. A cold plate MHQ setup has been assembled, and is
currently being tested in Delft. We expect that MHQ or
similar technology will allow preparing samples with ageing
times ultimately within 5–10 As.
One of the great advantages of the MHQ technique is the
unique opportunity to analyze the same sample by a number
of spectroscopic techniques, thereby greatly increasing its
analytical potential. For the near future we foresee applica-
tions in high frequency EPR, FTIR, resonance Raman,
EXAFS, MAS-NMR, and Mo¨ssbauer spectroscopy. Cur-
rently, the dilution of the sample in the cryomedium and the
electrostatic nature of the fine protein powder have been
severely limiting analysis of the freeze-quenched samples
by these spectroscopic techniques, with the exception of
resonance Raman spectroscopy.
The power of MHQ is illustrated well by the results
obtained with the two examples detailed in this work,
binding of azide to metmyoglobin from horse heart, and
reduction of dioxygen by cytochrome bo3 ubiquinol oxidase
from E. coli. In both cases, (novel) rapidly formed transient
intermediates have been detected, and their kinetic and
spectral properties characterized. In the near future, we
expect application of MHQ for studies on molecular mech-
anisms of catalysis not only of metalloproteins but also of
any enzyme that is changing its spectroscopic signature
during turnover. MHQ may well prove to be one of the key
approaches in the scientific developments towards under-
standing the laws of structure–function relationship in the
uniquely evolved biological catalysts, the enzymes.
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3.1. Chemicals
Metmyoglobin from horse heart and 2-hydroxycinnamic
acid were purchased from Sigma Aldrich NV, isopentane
was supplied by Fluka Biochemicals, Triton X-100 and h-
octyl glucoside was from Sigma, h-dodecyl maltoside
originated from Anatrace. Argon (6.0 grade) was used
for the anaerobic maintenance and operation of the
freeze-quench instrument.
3.2. Purification of cythochrome bo3 oxidase
Ubiquinone-free cytochrome bo3 oxidase from E. coli
was prepared essentially according to Rumbley et al. [222].
For exchange of Triton X-100 and h-octyl glucoside, the
enzyme was additionally passed through the POROS HQ
column (70 ml) pre-equilibrated with 25 mM K–phosphate
buffer in 0.05% h-dodecyl maltoside (LM), pH = 8.3
(Buffer A). The column was washed with at least 30
column volumes of buffer A until the absorbance at 260
nm of Triton-X100 subsided; the enzyme fraction was
subsequently eluted in 10 column volumes of a linear
gradient 0–1 M of NaCl in buffer A. The enzyme fraction
was concentrated to a 25 mg ml 1 (f 170 AM) solution,
desalted to 10 mM K-phosphate, pH = 7.5, 0.05% LM
using 100-kDa cutoff CentriPrep concentrators (Amicon),
and stored in aliquots of 300 Al at  80 jC. The enzyme
preparation was homogeneous for >96%; the enzyme
contained heme b and heme o in a 1:1 ratio as previously
described [248]. Approximately 200 mg of cytochrome bo3
oxidase was purified from 2.3 kg wet weight of GO105 E.
coli cells.
3.3. MHQ instrumentation
The freeze-quench setup (Fig. 2, 1–16) was assembled
from parts obtained from different suppliers.
3.3.1. Sample loading and delivery
HPLC pumps (Fig. 2, 13-1, 13-2) were supplied by
Waters Chromatography, Rheodyne-type sample injection
valves (Fig. 2-12), PEEK sample delivery tubing (blue
stripe), T-type connectors, 5-Am and 0.2-Am in-line sol-
vent filters (Fig. 2-11), Hamilton sample loading syringes,
and PEEK ferrule connectors originated from Supelco.
3.3.2. Vacuum maintenance
Low-pressure chamber (Fig. 2-1), RV5 oil vacuum
pump (Fig. 2), Piranhi vacuum gauges, air admission
valves, two-way valves, NW-type stainless steel vacuum
lines, and AGC active vacuum gauge controller were
purchased from Edwards. The base-plate for the low-
pressure chamber (Fig. 2-9), and LN2 trap (Fig. 2-10)
were homemade.3.3.3. Mixer, and mixer positioning
A stainless steel rod holder (Fig. 2-2) equipped with a
90o bracket swinging-arm (Fig. 2-3) was obtained from
Oriel Instruments. The tangential micro-mixer (Fig. 2-3)
was constructed in house (see Figs. 3 and 4). Platinum
inlays were purchased from Provak GmbH.
3.3.4. Cryomedium storage
Stainless steel LN2-grade dewars of 3, 2, and 1 l were
purchased from Cambridge Instruments. Isopentane samples
were prepared, cooled, and stored in the gastight 75-ml
ultracentrifuge tubes from Beckman.
3.4. Operation of the MHQ setup
3.4.1. Preparation, and handling of the cryomedium
A cold isopentane bath for short-term storage of the
samples and cryomedium was made in a 3-l dewar. Iso-
pentane (f 2 l) was cooled to 125 K by adding LN2. For
sample preparation, the Beckman ultracentrifuge tube was
filled to the top with fresh isopentane at room temperature,
tightly closed, and dipped into the isopentane bath for
equilibration to 125 K (f 15 min). Just before the evacu-
ation, the tube was withdrawn from the bath, opened, and
cold isopentane was rapidly poured into the sample collec-
tion vessel (Fig. 2-7) pre-cooled to 77 K. After cryofixation,
the isopentane-sample suspension was transferred back in
the tube pre-cooled to 77 K, closed and inserted in the 125
K bath for storage until further use.
3.4.2. Sample preparation
Reaction components were diluted to the concentrations
and pH indicated in the figure legends. Different concen-
trations of sodium azide were prepared by serial f 2-fold
dilutions of the pH-equilibrated f 3 M stock solution into
the working buffer of the appropriate pH in the 50-ml
polypropylene Falcon tubes. To calculate the dilution coef-
ficients with high accuracy, solutions were weighed on
analytical balances with 0.2 mg precision.
Three hundred microliters of the ‘‘enzyme’’ component
and 1.5 ml of the ‘‘substrate’’ component were used for the
preparation of each sample (total quenched sample vol-
ume—0.6 ml). The ‘‘substrate’’ and the ‘‘enzyme’’ solu-
tions were filtered through a 0.22 Am filter (Corning).
Prior to loading of the components, the ‘‘enzyme’’ solution
was additionally cleared by sedimentation in an Eppendorf
centrifuge at 14,000 rpm for 3 min. The reaction compo-
nents were loaded via the Rheodyne-type sample injection
valves, equipped with the sample-loading loops of the
required volume (PEEK tubing, blue stripe). In the case
of cytochrome bo3 oxidase, the ionic strength of the
enzyme solution was increased by addition of 1/10 volume
of 0.5 M K–phosphate, 5 M KCl, pH = 7.5. The enzyme
solution (f 150 AM) was transferred in the gastight
vessel; anoxic conditions were achieved after several
cycles of degassing and purging with Ar gas. The enzyme
A.V. Cherepanov, S. de Vries / Biochimica et Biophysica Acta 1656 (2004) 1–31 25was reduced by addition of ascorbate and PES to a final
concentration of 10 mM and 5 AM, respectively. The
extent of reduction was monitored in situ by UV–Vis
spectrometry at RT through the vessel walls. For the
freeze-quenching experiments, 300 Al of reduced bo3
oxidase were withdrawn in a O2-free gastight Hamilton
syringe and loaded in a Rheodyne-type injection valve,
which was pre-purged with anaerobic solvent and, prior to
loading, flushed with an anoxic 10 mM ascorbate, 5 AM
PES solution in 20 mM K–phosphate buffer, pH = 7.5. To
trigger the reaction, the oxidase solution was mixed in 1:1
ratio against 60 mM K-phosphate buffer, 0.5 M KCl, pH=
7.5, saturated with O2.
3.4.3. Standard operating procedure of the MHQ device
With isopentane as a liquid cryomedium, the standard
operating procedure of the MHQ device is as follows (see
Fig. 2). Between the sample preparation events, the mixer is
continuously purged at a low flow rate (0.2–0.4 ml min 1)
with a sample-free anaerobic carrier solvent, 10 mM NaCl,
which is delivered by two HPLC pumps, installed in parallel
(Fig. 2-4, 13-1, 13-2). The solvent is kept anoxic by
continuous bubbling of Ar gas (Fig. 2-16) through the
solvent container (Fig. 2-14). Addition of salt prevents
accumulation of static electricity on the jet (Fig. 2-5), and
jet break-up due to electrostatic repulsion. Anaerobic con-
ditions minimize orifice clogging, perhaps due to minimal
oxidation of the hastalloy mixer surfaces. In the mixer
purging mode, the carrier solvent is collected in a container
(Fig. 2-6), which is placed inside the f 50-l chamber
admitted to atmospheric pressure (Fig. 2-1). Just before
evacuation ( < 0.5 min), 75 ml of a cold cryomedium
quencher (isopentane or ethane at 125 K) is poured into a
pre-cooled (77 K) vial (Fig. 2-7), which is placed inside the
chamber next to the solvent collection container. Immedi-
ately after that, the chamber is evacuated using a RV5 oil
vacuum pump (Fig. 2-15). During evacuation (2–3 min),
the solvent flow rate is increased to the desired value. The
AGC controller is programmed to maintain the pressure in
the chamber between 100 and 120 mbar. After the pressure
in the system reaches this value, the samples are injected in
1:1 ratio into the mixer via the two Rheodyne-type injection
valves (Fig. 2-12). To increase the quality of the sample
plug-flow, the injection valves are connected to the mixer
with a small-inner-diameter PEEK HPLC tubing. Before
entering the mixer, both ‘‘enzyme’’ and ‘‘substrate’’ solu-
tions pass through 5- and 0.2-Am in-line solvent filters (Fig.
2-11) installed between the valves and the mixer. The
volume of one of the reaction components (substrate) is
taken roughly fivefold larger than the volume of the other
component (enzyme) (1.5 vs. 0.3 ml), and the substrate is
injected first with a short advance (f 0.5 ml). In this way
the mixing chamber is purged with the substrate before the
enzyme arrival, so that the substrate concentration in the
mixing chamber is constant during the enzyme injection,
providing, at excess of the substrate, pseudo-first orderreaction conditions, and mixing of the reaction components
at 1:1 ratio.
To collect the sample, the mixer, attached to a swinging
arm (Fig. 2-3), is rotated inside the low-pressure chamber
from spraying into the solvent container to spraying into
the vial containing vigorously mixed cryomedium (Fig. 2-
8). After collection, the mixer is returned back to spray in
the solvent container, and the air is admitted. The whole
procedure takes 3–5 min, depending on the sample flow
rate. During the sample preparation, the cryomedium
warms up by f 25–30 degrees to 150–155 K. After air
admission, the cryomedium slurry containing MHQ sample
is rapidly transferred to a pre-cooled Beckman ultracentri-
fuge tube (77 K) and immersed in the cold isopentane bath
equilibrated at 125 K. The next sample is prepared
accordingly.
3.4.4. Sample packing and analysis
Optical absorbance spectroscopy. The 77 K optical
absorbance spectroscopic analysis was carried out using
an SLM-Aminco DW-2000 scanning spectrophotometer in
the split-beam mode equipped with a low-temperature
spectroscopy set up. The sample suspension in isopentane
(f 600 Al of myoglobin–azide mixture per f 75 ml of
isopentane) was used for spectral analysis directly without
additional treatment (e.g. sample concentration). The ap-
propriate 2 1-ml sample/reference cuvette holder was
pre-equilibrated to 77 K under LN2. The sample-isopen-
tane suspension was rapidly ( < 1–2 s) pipetted from the
storage tube into the cuvette using a pre-cooled Eppendorf
pipette tip (1 ml, blue). The reference cuvette was filled
with the buffer-isopentane suspension accordingly. Isopen-
tane was allowed to freeze, and the cuvette holder was
transferred to the spectrophotometer for recording of the
spectrum.
X-band EPR. EPR spectra were recorded on a Varian E9
spectrometer equipped with a home built He-flow system
[249]. In our hands it proved impossible to pack the fine
suspension of the MHQ sample into the X-band EPR tube
(4-mm i.d.) using any conventional means, e.g. steel-rod
packing [49,130] or pressure-filtering [250]. To overcome
this problem, a cold centrifugation setup, employing 6 L-M
Beckman centrifuge equipped with a wind-shielded 6 1-
l swing-out rotor, has been assembled. A homemade Al
holder for the sample and EPR tube was designed and
machined (Fig. 20). In addition, EPR tubes were cut to
f 6-cm length to fit into the holder. To accommodate the
holder in the swingout bucket, an additional adapter was
machined as well. For sample packing by cold centrifuga-
tion, the holder with the mounted EPR tube and the swing-
out buckets are pre-equilibrated to 77 K under LN2. The
holder is incompletely immersed in LN2 to avoid accumu-
lation of liquid nitrogen inside the holder and/or EPR tube.
Just before centrifugation, the sample suspension in iso-
pentane (f 30 ml) is rapidly poured inside the holder.
Almost simultaneously, the swing-out buckets are with-
Fig. 20. EPR tube holder for concentration/packing of the sample
suspension in the cold centrifugation setup. 1—Polypropylene lid; 2—
holder body machined in solid Al; 3—the stopper-screw. A 60 mm-long
EPR tube is placed inside the holder with the screw closed, so that the
bottom of the tube rests on the screw end. The holder with EPR tube is pre-
cooled to 77 K, f 30 ml of sample slurry is poured inside the ‘‘funnel’’
top, the lid is closed, and the sample is packed by centrifugation as
described in Experimental procedures. For further comments, see text.
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poured inside the wind shield, the holder(s) with the
sample(s) are placed in the rotor, the windshield is closed,
and the sample is centrifuged for 5 min at 6000 rpm.
Optionally, a stream of cold N2 gas can be pumped through
the centrifugal chamber to prevent warming of the sample.
At average, one run takes 6–8 min. Without cold gas flow,
the sample warms up during centrifugation to f 150–170
K; short time of exposure of the sample to 170 K (1–2
min) does not allow the reaction to proceed further. After
centrifugation, the sample holder is placed under LN2 for
15–20 s. Subsequently, the screw on the bottom of the
holder is removed; the EPR tube with the sample is pushed
out with the metal rod through the opening in the bottom,
and placed in LN2 for the further storage. Between the
sample centrifugation events, the centrifuge is allowed to
equilibrate to RT to prevent damage of the motor and
electronics.3.5. Stopped-flow experiments
Transient state kinetic experiments were performed on
the Bio Sequential Stopped-Flow Reaction Analyzer SX-18
MV (Applied Photophysics, Leatherhead, UK) using an
ozone-free 150-W xenon arc light source. For the kinetic
experiments, horse heart metmyoglobin was diluted in the
buffer of the appropriate pH to a concentration of 22 AM (11
AM after mixing). All metmyoglobin stocks were stored on
ice and used within 1 h after preparation. For the stopped-
flow experiments, metmyoglobin and azide stocks were
incubated in the syringes for 5 min and mixed at 1:1 ratio.
The SX-18 MV software package for the single-wavelength
operation mode was used for data acquisition in both
absorbance (408 nm), and fluorescence mode. Tryptophan
emission was excited at 280 nm and measured as the light
passed through a 320-nm cut-off filter. Kinetic traces were
obtained by averaging 3–10 shots (optical absorbance at
406 nm) or 10–15 shots in case of protein fluorescence
emission under conditions when the observed rate constant
did not exceed 800 s 1. The number of shots was increased
to measure faster binding, and in some cases up to 150–200
traces were used for averaging.
3.6. Mixing efficiency assay
The mixing efficiency was assayed by following the
quenching of the fluorescence emission in the course of
protonation of 2-hydroxycinnamic acid (2-HCA). For the
assay, the 0.5 AM 2-HCA solution in H2O, or in the
water–glycerol solution at concentrations indicated in the
text, was used at pH = 9.5. Fluorescence was quenched by
mixing the 2-HCA solution with 20 mM HCl. Fluores-
cence emission was monitored using a Zeiss Axioplan 2
Trinocular Epi-Fluorescence Research Microscope with
Transmitted Light Brightfield and Phase Contrast,
equipped with the Epiplan LD objective, 50 /0.50
d = 0, a= 6.9 mm, and 450–600-nm filter. To digitize the
image, a Hitachi CCD camera and the Leica Qfluoro v. 1.1
software package were used. The mixer was positioned
under the microscope so that the point of observation was
directed at the point of exit of the jet from the mixer, i.e.
f 0.8–1 mm away from the orifice in the platinum inlay.
The focal depth of the objective is F 2 Am; the objective
was focused on the center of the jet in the direction
perpendicular to the vector of the jet velocity. The result-
ing image represents a radial slice through the jet with a
focal thickness of f 4 Am and a length along the
propagation direction of f 0.1 mm (see also Fig. 5). At
187 m s 1 jet speed, the temporal slit width of the
observation field is f 0.5 As.
The mixing efficiency was calculated by comparing the
values of total light intensity of the acquired images. Total
light intensity was calculated by integration of the pixel
intensity values from the corresponding image.tif file. Ap-
proximately 50–60 images obtained under identical con-
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glycerol concentration. The average intensity of the 2-HCA
solution mixed with water was taken as 100% intensity
(Imax). The average intensity of water (or water/glycerol
mixture) mixed with 20 mM HCl (Imin) was taken as 0%
intensity. The mixing efficiency (g%) has been calculated at
each glycerol concentration from the average intensity of 2-
HCA solution mixed with 20 mM HCl (Imix) using the
following correlation.
g% ¼
Imix  Imin
Imax  Imin  100
3.7. Data analysis
Processing of the spectral and/or stopped-flow data,
analysis, fitting, and minimization was performed in the
Igor Pro v. 4.16 software package (Wavemetrics). Error
estimates for the data in graphs and tables represent the
standard deviation values.
3.7.1. Weighted fitting of the EPR spectra with a high-term
polynomial function
To subtract a baseline in the EPR spectra the following
procedure was followed. A spectrum was created of the
same field range as the EPR spectra of interest, and filled
with artificial ‘‘standard deviation’’ values. A low standard
deviation value was assigned to the field regions of the
spectrum of interest that contain no informative signals,
while a 30-fold higher deviation was set for all regions
where the resonances are located. For metmyoglobin, the
areas of HS and LS resonances were chosen by eye from
two high signal-to-noise spectra (at f 2 mM metmyoglobin
species); for each signal f 1.5 times the peak width around
the peak maximum was taken. The thus obtained artificial
‘‘standard deviation’’ spectrum, which contains low devia-
tion values in the baseline regions and high deviation values
in the resonance regions, was used for the weighted poly-
nomial fitting. In the weighted fitting procedure with a high-
term polynomial function k0 + k1x + k2x
2 + . . . + knx
n, every
data point of the spectrum of interest was analyzed by a
singular value decomposition fitting algorithm according to
its ‘‘weight’’—a standard deviation value that was stored in
the artificial ‘‘standard deviation’’ spectrum. As a result, the
high-term polynomials were fitted to the regions of the
spectrum with low standard deviation values that contain
broad baseline curvatures (Fig. 9A, dotted traces). On the
other hand, the informative regions of the spectrum con-
taining sharp HS and LS signals were ‘‘excluded’’ from the
fitting procedure because of their high standard deviation
values, and, basically, a linear regression was fitted to these
regions. Thus, the output fitting residuals (Fig. 9B and C)
preserve maximum information from the ‘‘signal’’ regions,
while the off-peak areas essentially converge to the instru-
ment noise around zero.Acknowledgements
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